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GENETIC VARIATION IN POTENTIALLY VIRULENT VIBRIO  
 
PARAHAEMOLYTICUS FROM THE NORTHERN GULF OF MEXICO 
 




 Vibrio parahaemolyticus (Vp) is a gram-negative bacterium found naturally in 
marine and estuarine environments. Vp is found in oysters including those which are later 
consumed by the public. Sub-populations of potentially virulent Vp contain specific 
virulence factors and are relevant human pathogens capable of causing gastroenteritis, 
wound infection, and death. The tdh and trh genes, both encoding hemolysins, have been 
correlated with the majority of clinical Vp isolates but have not been shown to be the 
definitive virulence factors. 
A total of 146 Vp isolates from the northern Gulf of Mexico were collected and 
probed for the presence of specific virulence factors such as tdh, trh, Type III secretion 
System (T3SS) 1, T3SS2α, T3SS2β, and toxRS. The most representative sub-group of 
potentially pathogenic Vp were tdh+/trh+. Isolates containing only tdh were uncommon, 
and tdh-/trh+ isolates were extremely rare.  
The distribution of virulence factors in environmental Vp strains was compared 
with strain fitness through Vp human intestinal epithelial cell cytotoxicity assays and 
oyster (Crassostrea virginica) hemocyte bactericidal challenges. The assays were 
performed to determine significant differences in cytotoxicity or bactericidal survival 





 Significant changes in Vp gene expression were measured for representative 
clinical strains of the diametric virulence factor sub-groups tdh+/trh- and tdh-/trh+. 
Transcriptomic changes were measured during exposure to human intestinal epithelial cells 
and oyster hemocyte. Relative changes in the Vp transcriptome were compared both over 
time and between strain to give significantly regulated genes involved in cytotoxicity and 
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Vibrio parahaemolyticus (Vp) is a gram-negative, facultatively anaerobic motile 
rod-shaped bacterium. Vp was originally described in 1954 (1)  after it was isolated as the 
causative agent of “summer diarrhea” in Japan. Due to its halophilic nature, Vp is 
ubiquitous in marine and coastal environments (2, 3). A characteristic member of the 
Gammaproteobacteria, Vp is both ecologically and medically important (4-6), affecting 
local and regional human populations including those in the northern Gulf of Mexico. 
Vp is present in both the sediment and the water column (7) with cell densities 
showing significant correlation to temperature and, to a lesser extent, salinity (Johnson et 
al in prep)(7). Aquatic organisms can also act as a biological reservoir for these bacteria. 
Vp can accumulate in filter-feeding molluscs, including oysters in densities of over 100 
times that in surrounding waters (8); Vp is also found in the hemolymph of blue crabs (9, 
10), in shrimp homogenate (11), and on copepods (4, 12). 
Vp densities may be in high enough to cause illness in humans when oysters and 
other seafood are eaten raw or under-cooked. The FDA estimates the infective dose to be 
1x106 colony forming units (cfu) (13).Virulent Vp can cause gastroenteritis, wound 
infections, and septicemia (14-17). Although the first recorded evidence of Vp-induced 
disease was in 1954, outbreaks out Vp are reported worldwide today (18-21), especially in 
countries where large amounts of seafood are consumed. It has been estimated that there 
are as many as 4,500 cases of Vp infections per year in the US, with 30 hospitalizations 
and 1-2 deaths (22). Although outbreaks of disease-causing Vp are not rare, potentially 
virulent Vp represent a minor subpopulation (<10%) of the overall Vibrio community in 




In 1969, clinical Vp isolates were tested on a newly developed specialized blood 
agar called Wagatsuma agar (3). Japanese scientists observed that some Vp strains 
exhibited hemolysis on Wagatsuma agar.  The occurrence of this β –hemolysis was coined 
the “Kanagawa phenomenon” (KP) and was correlated with clinical strains (3).  
Specifically, Vp isolates from 128 dysentery patients and 308 patients with food-poisoning 
were plated onto Wagatsuma agar where β –hemolysis was observed in 95.3% and 88.3% 
of strains, respectively (3).  In 1980, KP was shown to be caused by a novel hemolysin, 
Thermostable Direct Hemolysin (TDH), encoded by the tdh gene (26).  In 1988, a second 
hemolysin was identified in a tdh- KP- clinical strain.  The second hemolysin had 
extremely similar immunological characteristics to TDH, except that it was heat labile 
unlike TDH; it was named the TDH-related hemolysin (TRH) (27).  Like TDH, TRH 
contains two subunits and the amino acid sequences encoding both hemolysins shares 
roughly 67% homology. 
 In multiple studies over several years, 90% of 784 clinical Vp isolates were found 
to contain either tdh, trh, or both (3, 28, 29), while similar studies found less than 1% of 
environmental isolates carried either gene (3, 30).  A recent study done in coastal 
Mississippi found that between 4-5% of total environmental isolates carried either tdh or 
trh (31).  The presence of both tdh and trh production has been correlated with human 
pathogenic Vp; therefore strains containing tdh and/or trh are considered ‘potentially 
pathogenic’. Each hemolysin has been associated with pathogenicity in varying degrees.  
One study of 214 clinical strains showed that 52.3% were tdh+/trh- , while 24.3% were tdh-
/trh+ (29).  Another study in Calcutta, India observed that 90% of isolates taken from 
clinical patients were tdh+/trh- compared to just 0.8% for tdh-/trh+ strains (32).  A study in 




It should be noted that tdh and trh are not present in all clinical strains (34) and 
therefore do not fully account for Vp pathogenicity or virulence (35).  Studies of a tdh-
deleted Vp strain revealed that even without TDH production, effects of cytotoxicity and 
enterotoxicity were still observed, although in reduced amounts (36, 37).  As mentioned 
earlier, roughly 10% of 784 clinical isolates from several studies did not contain either the 
tdh or the trh gene.  In 1990, an experiment was performed which examined the virulence 
of both tdh+ and tdh- Vp isolates in mice (38).  The calculated LD50 was found to be 107 
and 108 for each isolate, respectively.  These findings led the researchers to conclude that 
although tdh+ isolates were found predominantly in human clinical cases, lethality between 
tdh and trh in mice remained equal.  Therefore, other factors must be responsible for the 
overall enteropathogenic affects of Vp. 
Vp has several distinct pandemic serotypes. Vp is typed by the presence of O 
antigen (the lipid moiety outer membrane lipopolysaccharide) and K antigen. Prior to 
1996, isolates from international clinical cases displayed a wide range of these antigens. 
Due to the varied nature of these serogroups, no true Vp pandemic serotype was identified.  
In a study of 86 clinical Vp isolates obtained  in Japan and Thailand between 1962 and 
1999, it was shown that before 1996 there was no predominant clinical strain of (39).  One 
exception was observed in a study of clinical isolates originating in the United States from 
1979 to 1987.  In this study the majority of infections (71%) were shown to be urease 
positive. Of the urease positive isolates, 59% were associated with a single serovar, 
O4:K12 (40). All O4:K12 isolates in this study were urease positive. This was the first 





A study in Calcutta, India monitored hospitalized patients for a period of several 
years, and in February of 1996 a rapid and distinct change to the antigenic pattern in 
clinical strains of Vp was seen (32).  A single predominant serovar, O3:K6 (32, 39), was 
observed in ~65% of all cases in 1996 but not in the initial two years of observation.  This 
O3:K6 strain was different from previously isolated O3:K6 strains as it contained tdh but 
not trh (41), and thus was termed the ‘new’ O3:K6.  Interestingly, the new O3:K6 serovar 
had not been isolated previously to February of 1996, leading scientists to conclude that 
this O3:K6 serovar was a unique novel clone (32).  During a high-incidence period in 1996 
(from February to August), the new O3:K6 serovar comprised ~75% of all isolated strains 
(42).   
 The new O3:K6, the major pandemic Vp serovar since 1996, has prompted a 
tremendous amount of research into classifying both the pandemic strain and closely 
related strains (21, 41-44).  Several closely related serotypes- O1:K25, O1:K26, O1:KUT 
and O4:K68, were discovered to also have pandemic potential and may have originated 
from the new O3:K6 clone (41, 43-47).  All of the identified potentially-pandemic 
serotypes contained tdh but not the trh gene.  A method was developed to test the 
pandemic-specific group of Vp in 2000, when it was discovered that the toxRS operon 
sequence in pandemic-causing strains had a slightly differing nucleotide sequence than 
non-pandemic strains (41).  The proteins encoded by toxRS are trans-membrane proteins 
that are well documented regulators in the Vibrio genus (48-50).  Investigators took 
advantage of the sequence divergence and developed a PCR method entitled Group-
Specific PCR (GS-PCR) which only amplified pandemic-group Vp toxRS sequences. 
 Pathogenicity in Vp has been strongly correlated with tdh and trh but has not been 




with these two hemolysins may also contribute to the pathogenicity and virulence of Vp.  
In 2003, the sequencing of Vp O3:K6 strain RIMD 2210633 revealed a new virulence 
factor: the type III secretion system (T3SS) (23).  The T3SS is a needle-like protein 
complex found on the surface of some gram-negative bacteria.  The rod-shaped needle can 
form pores in the membrane of eukaryotic cells and inject specific proteins known as 
effectors into the cytosol or environment in response to certain cellular signals or 
environmental conditions (51, 52).  The genes encoding the T3SS are typically found 
clustered together and are commonly found within mobile genetic elements such as 
pathogenicity islands (52, 53). 
The RIMD2210633 genome revealed not one but two distinct T3SSs: T3SS1 and 
T3SS2, located in genetic clusters on chromosomes 1 and 2, respectively.  Both T3SSs are 
genetically non-redundant and T3SS1 is associated with cytotoxicity while T3SS2 is 
correlated with enterotoxicity (54).  The T3SS1 in Vp was found to be genetically related 
to the plasmid-encoded T3SS of Yersinia pestis, while T3SS2 has been related to the T3SS 
system found in Shigella spp.  T3SS1 was found to be ubiquitous in Vp while T3SS2 was 
found only in KP+ isolates (34, 55).  The association of KP+ isolates with T3SS2 was 
elucidated when the genes encoding T3SS2 were found residing on an 80kbp pathogenicity 
island (23, 56).  This pathogenicity island also contained two copies of tdh, effectively 
flanking the T3SS (23, 55, 57).   
 In 2009, a third T3SS variant was discovered in a tdh-/trh+ strain (58) located on 
chromosome 2 in the location of T3SS2 in KP+ strains.  A study of environmental isolates 
from the northern Gulf of Mexico revealed that the new T3SS variant was found in 5/5 tdh-
/trh+ isolates and 0/153 non- tdh-/trh+ isolates (59).  After discovery of this new T3SS 




The new T3SS variant was named T3SS2β.  Thus T3SS2α has been associated with 
tdh+/trh- strains while T3SS2β has been associated with tdh-/trh+ strains.  Only a minor 
amount of research has been done concerning the toxicity of T3SS2β due to its recent 
discovery. 
Little is known about the T3SS functions in regards to the ability of Vp to enter and 
survive inside oyster tissue.  Several T3SS genes and their products have been 
characterized in Vp since 2003 (60-63), including most structural genes.   Many effector 
genes and their products have been of particular interest to researchers seeking to 
understand T3SS-induced toxicity (37, 60-65).  Conversely, there is very little information 
regarding which products of T3SS genes are expressed during invasion of Vp in oyster 
tissue and hemolymph.  
The distribution of virulence factors in Vp isolated from environmental sources 
remains unclear. It has been shown that the fitness of Vibrios in the environment is the 
result of a combination of genetic factors (66, 67). Therefore, the presence and production 
of virulence factors such as the T3SS may confer some change in a strain’s ability to 
colonize different environmental compartments such as the water column, biofilms, in 
sediment, and the exterior and interior of animals such as filter-feeding oysters. 
 Vp is widely detectable in oysters harvested from marine and estuarine 
environments.  Studies in the northern Gulf of Mexico have shown that Vp is detectable in 
oyster meat during both warm and cool seasons (7).  Although potentially pathogenic Vp is 
found at detectable levels in oyster meat, tissue necrosis is not a concern. Conversely, 
potentially pathogenic Vp causes both cytotoxicity and enterotoxicity in humans.    
Although a large amount of research has focused on characterization of virulence 




pathogenic Vp and their function in the environment.  For instance, it is unknown whether 
the cytotoxicity of potentially pathogenic Vp varies significantly between strains carrying 
tdh or trh.  It is also unknown how well the presence of T3SS2 variants α and β correlates 
with the presence of hemolysins.  More research is needed to understand these rare, 
naturally-occurring bacteria in ecologically-relevant situations such as the colonization of 
oysters.  The ability to understand how naturally-occurring, potentially pathogenic Vp 
function in the environment is paramount for developing more effective public health plans 
and seafood treatment methods. 
 The purpose of this study was to examine collections pathogenic and potentially 
virulent Vp from environmental sources through the accomplishment of several goals.  
• First, the distribution of the virulence factorT3SS was examined in a large pool 
of environmental potentially pathogenic Vp. The distribution of virulence 
factors such as tdh, trh, TSSS1, T3SS2α, T3SS2β, and toxRS was correlated to 
help better explain their respective role in environmental Vp functions.  
• The correlation of virulence factors and Vp strain fitness was accomplished 
through Vp human intestinal epithelial cell cytotoxicity assays and oyster 
(Crassostrea virginica) hemocyte bactericidal assays. These assays were 
performed and significant differences in cytotoxicity or bactericidal survival 
between virulence factor subgroups (tdh+/trh-, tdh-/trh+, tdh-/trh+) was 
examined.  
• Significant changes in Vp gene expression was measured for representative 
clinical strains of the diametric virulence factor sub-groups tdh+/trh- and tdh-
/trh+. Transcriptomic changes were measured during exposure to human 




transcriptome were compared both over time and between strain to give 







DISTRIBUTION OF TYPE III SECRETION GENES IN V. 
PARAHAEMOLYTICUS FROM THE NORTHERN GULF OF MEXICO 
One hundred and thirty potentially pathogenic environmental Vp were selected 
from roughly four thousand cultured environmental Vp strains. Three separate 
environmental sources (water, sediment, and oyster meat) from the northern Gulf of 
Mexico were used for sampling purposes. The 130 isolates comprised roughly 3-5% of 
total colonies screened from environmental samples (7) and were considered potentially 
pathogenic due to the presence of one or both of the hemolysin genes tdh and trh. Both tdh 
and trh were putatively identified in a preliminary colony hybridization screening process. 
All isolates were screened for the virulence factors tdh, trh, T3SS1, T3SS2α, and T3SS2β.   
All isolates were also examined for a group specific toxRS genetic sequence found in 
pandemic-causing strains as previously described (GS-PCR)(18, 41).   
Materials and Methods 
Sample Collection.  Samples were collected in two separate sampling periods with the first 
sampling period occurring from October 2006 to August 2007 at sampling sites MS2, 
MS5, MS6, and MS8.  A second sampling period occurred from February to May of 2009 
at sites MS2 and MS8.  No sampling occurred in 2008 and sampling was limited to two 
sites in 2009 for logistical purposes.  Water, oyster, and sediment samples were collected 
from the sites in the Mississippi Sound (MS) at the following coordinates:  MS2 (30o17.4’ 
N, 89o17.3’ W); MS5 (30o37.6’N, 88o83.2W); MS6 (30o36.6’ N, 88o67.5’W); and MS8 





Figure 1. Locations of the four sampling sites along the Mississippi Gulf Coast. Sampling 
sites were designated MS-2, MS-5, MS-6, and MS-8. 
 
  Water (6- to 8- liter volumes) was collected in autoclaved plastic containers.  Water 
conditions varied throughout the sampling period but demonstrated  little inter-site 
variation.  Specifically, the average temperature/salinity was 19.23oC and 17.73ppt for site 
MS2, 22.6oC and 22.5ppt for site MS5, 24.6oC and 21.88ppt for MS6, and 20.6oC and 
18.1ppt for site MS8.  Live oysters (8-15 each sampling trip), water, and sediment were 
collected as previously described (7).   Vp densities were determined using a previously 
described direct plating/colony hybridization method (68), for detection of tdh, trh, and 
thermolabile hemolysin (tlh). 
Characterization of environmental isolates.  The total collection of 130 “potentially 
pathogenic” Vp used in this study were collected over the course of two years comprising 
over 70 sampling trips and 210 independent enrichments.   The tlh+, tdh+, trh+, and 




Colony Hybridization method (DPCH).  In addition, tlh, tdh, and trh were confirmed using 
gene specific polymerase chain reaction (PCR) and agarose gel electrophoresis.   
 Genomic DNA was extracted from each isolate as described previously (7, 69) and 
confirmed isolates were stored at ambient room temperature (c.a. 23oC) in soft T1N3 agar 
deeps (1% tryptone, 3% NaCl, pH 7.2, 0.7% agar).  During the sampling period, 130 tdh+ 
and/or trh+ Vp isolates were collected for screening of additional virulence factors. Sixteen 
tdh-/trh- isolates were chosen randomly to act as negative controls.  Twelve clinical isolates 
were also included in the analysis and obtained from the U.S. FDA, Alaska Division of 
Public Health, American Type Culture Collection, or isolated locally (Table 1).  
Table 1 
 
Source of clinical isolates used in this study 
 
 
Strain ID  Origin 
 
BAA-238  ATCC 
 
BAA-240  ATCC 
 
AQ 4037  A. DePaola, FDA, Gulf Coast Seafood Lab –tlh+/tdh-/trh+ control 
 
FIHES 98  A. DePaola, FDA, Gulf Coast Seafood Lab –tlh+/tdh-/trh- control 
 
Tx2103  A. DePaola, FDA, Gulf Coast Seafood Lab –tlh+/tdh+/trh- control 
 
AK-PHL  T. Franklin, Alaska DPH; infection originated in New Orleans, LA 
 
F11   A. DePaola, FDA, Gulf Coast Seafood Lab 
 
CT6636  B. Tall, FDA – clinical isolate from Connecticut 
 
KCHD 613  B. Tall, FDA – clinical isolate from Washington 
 







Table 1 (continued). 
 
 
Ny3547  B. Tall, FDA – clinical isolate from New York 
 
Vp2007-095  Local clinical isolate 
 
 
Most clinical isolates were not local and were included to represent a variety of Vp 
genotypes which have caused human illness.  One clinical isolate, Vp2007-095, was the 
single local strain in our collection; it was acquired from a gastroenteritis patient (stool 
sample) who had eaten raw oysters. 
Screening of environmental and clinical isolates.  Three multiplex PCR screens 
were performed targeting T3SS1, T3SS2α, and T3SS2β.  The T3SS1 multiplex screen 
targeted open reading frames (orfs) designated as VP1670 (vscP), VP1686 (putative), 
VP1689 (vscK), and VP1694 (vscF).  The T3SS2α multiplex was designed to target orfs 
VPA1327 (vopT), VPA1335 (vscS2), VPA1339 (vscC2), and VPA1362 (vopB2).  The 
T3SS2β multiplex targeted genes vscS2, vscC2, vopC, and vopB2 specific for T3SS2β (58).  
A preliminary multiplex PCR was originally run against all 158 isolates and targeted 
VP1669 (vscO), VPA1346 (vopJ), VPA1354 (vscU2), and an internal control, VPA0226 
(tlh).  VPA0226, encoding a thermolabile hemolysin, was chosen as an internal control due 
to its ubiquitous presence in Vp.  Positive amplification of the internal control was 
confirmed in the preliminary multiplex before any of the 3 multiplexes were run 
All multiplex PCR screenings were carried out using gene-specific primers 
(Appendix A).  The primers used in this study targeting T3SS2β have been described 
previously (58).  All other primers, with the exception of primers targeting the hemolysins 




(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) and tested against self-
dimerization and hairpins using the IDT OligoAnalyzer 3.1 software 
(http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/).  The primers were 
screened against the published sequences of chromosomes 1 and 2 of the sequenced strain 
RIMD 2210633 and the entire known genetic sequence for T3SS2β+ strain TH3996 to 
ensure specificity and protect against cross reactivity.  Primer sequences were then run 
through BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi), using a modified BLASTN 
algorithm designed for oligonucleotide primers. 
  PCR cycling conditions for the tdh, tlh, and trh multiplex included an initial 
denaturation at 95oC for 2 minutes, 33 cycles of denaturation at 95oC for 45 seconds, 
annealing at 56oC for 45 seconds, and extension at 72oC for 40 seconds, and a final 
extension at 72oC for 3 minutes.  The amplification conditions for T3SS1 and T3SS2α 
multiplexes were set at one cycle of 95oC for 5 minutes, followed by 33 cycles of 
amplification consisting of denaturation at 95oC for 45 seconds, annealing at 60oC for 40 
seconds, and extension at 72oC for 45 seconds, and terminated by one cycle of final 
extension at 72oC for 3 minutes.  For the T3SS2β multiplex PCR parameters were assigned 
as previously described (58).  Group Specific PCR (GS-PCR), targeting a region of the 
toxRS specific to pandemic-causing groups, was performed as described previously (41). 
After amplification, the products were resolved by gel electrophoresis using a 1.3% 
agarose gel run at 200 volts in sodium borate buffer (SBB) to resolve 100-600 bp 
amplicons.  Primers were designed so that amplicon sizes were distinguishable for each 
multiplex set.  Agarose gels were then stained using Sybr Gold (Invitrogen, Carlsbad, CA).  
After staining, gels were viewed in order to record presence or absence of amplicons.  In 




confirm amplification of the correct product, a monoplex PCR for each gene target was run 
with the appropriate positive control- strain Tx2103 for T3SS1 and T3SS2α genes and 
strain AQ4037 for T3SS2β genes.  Amplicons from the monoplex were purified from 
agarose (Qiagen, Valencia, CA) and sent out for sequencing (McLab, San Francisco, CA). 
Recognition and identification of vopB2 using fluorescence in situ hybridization.  A 
technique known as Recognition of Individual Gene Flurescence in-situ Hybdridization 
(RING-FISH), originally documented in 2004 (70), was used to confirm the presence of 
virulence factors in specific Vp strains. Vp strains were grown overnight at 37oC in 1mL of 
alkaline peptone water (APW) and fixed as described previously (71) on 4-well, 5-mm 
teflon printed slides (Electron Microscopy Sciences, Hatfield, PA).  The vopB2 primers 
used for the development of an RNA probe were identical to the T3SS2α vopB2 primers 
used for the PCR screen with the exception that the forward primer contained an additional 
21-bp segment encoding the binding site of the T3-RNA polymerase (Appendix A).  
Transcription and probing was performed as described previously (70) with the following 
changes.  The vopB2 RNA probe was fluorescently labeled via incorporation of CY3-
dUTP (GE Healthcare) during transcription.  Hybridization was carried out with an initial 
step of 80oC for 20 minutes followed by 38oC for 24 hours in humidity controlled 
chambers.  After, hybridization slides were washed with deionized water and counter-
stained with Fluoro Gel II with DAPI (Electron Microscopy Sciences, Hatfield, PA).  
Slides were then placed in storage at 4oC.  All slides were viewed with a Zeiss Axiostar 
Plus microscope (Carl Zeiss, Germany) using the appropriate filter set.  Vibrio 
parahaemolyticus cells were examined in the appropriate slide well and counted.  Under 
visualization, if no cells produced a Cy3 fluorescence the result was considered negative.  




equally across the slide.  Some cells on positive slides did not produce fluorescence; 
however these cells generally were in areas of debris which may have affected the ability 
for the probe to bind.  Methodology and cell compatibility was first tested using the 
ubiquitous Vp gene tlh (K.J. Griffitt, unpublished data).  Cell images were acquired using 
Zeiss AxioCam MR camera and AxioVision software v4.7.1.0 (Carl Zeiss). 
Results 
Vp isolates were screened for genes representative of T3SS1, T3SS2α, and T3SS2β 
(Tables 2 and 3).   
Table 2 
 
Distribution of virulence factors in environmental isolates (n=146) 
 
 
  tdh+/trh- tdh-/trh+ tdh+/trh+ tdh-/trh-  
 
   
T3SS1  27/27  3/3  100/100 16/16 
 
T3SS2α 27/27  0/3  0/100  0/16 
 
T3SS2β 0/27  3/3  0/100  0/16 
 





Distribution of virulence factors in clinical isolates (n=12) 
 
 
  tdh+/trh- tdh-/trh+ tdh+/trh+ tdh-/trh-  
 
   
T3SS1  3/3  2/2  4/4  3/3 
 
T3SS2α 3/3  0/2  0/4  0/3 





Table 3 (continued). 
 
 
GS-PCR 0/3  0/2  0/4  0/3 
 
 
A total of 158 strains were tested in this experiment, 146 environmental strains and 
12 clinical strains. Among the 146 environmental isolates collected, 130 were considered 
potentially pathogenic (tdh and or trh) with 16 identified as non-pathogenic because they 
contained neither tdh nor trh. The 16 non-pathogenic isolates were selected at random as 
representative of the overall non-pathogenic Vp population.  A total of 12 clinical isolates 
(three tdh+/trh-, two tdh-/trh+, four tdh+/trh+, and three tdh-/trh-) were also tested. In total, 
100 (77%) of 130 potentially pathogenic Vp isolates were tdh+/trh+, 27 (21%) were 
tdh+/trh-, and 3 (2%) were tdh-/trh+.  Of the 12 clinical isolates tested, 2 were tdh-/trh+, 4 
were tdh+/trh+, 3 were tdh+/trh-, and 3 were tdh-/trh-.  All 158 Vp isolates tested positive for 
all 5 T3SS1 genes selected.   
Five genes associated with T3SS2α were used to screen the 158 isolates.  Of the 
146 environmental isolates, 27/27 tdh+/trh- isolates tested positive for 4 out of 5 T3SS2α 
genes, with all 27 testing negative for vopB2.  All 3 tdh+/trh- clinical isolates tested positive 
for all T3SS2α genes, including vopB2.  No other isolate tested positive for any T3SS2α 
gene.  The presence/absence of vopB2 was confirmed using recognition of individual gene 
fluorescence in situ hybridization (RING-FISH) with specific gene probes as described 
previously (70).  All 3 clinical tdh+/trh- strains exhibited the normal positive signal pattern 
after hybridization with a 250-bp VPA1362 RNA probe, while 27/27 environmental 





Figure 2. Representative images of Vp isolates tested using RING-FISH for T3SS2α gene 
vopB2.  (A.)  1000X magnification DAPI image of tdh+/trh- vopB2- environmental isolate 
2007-103.  (B.) Cy3 image of identical slide location for environmental isolate 2007-103.  
(C.)   DAPI image of vopB2+ clinical isolate Tx2103.  (D.)  Cy3 image of identical slide 
location for clinical isolate Tx2103 
 
Aside from vopB2, no gene was detected differentially between clinical and 
environmental isolates.  Therefore RING-FISH was run solely for the vopB2 gene. 
Group-specific PCR (GS-PCR), targeting a region commonly associated with 
tdh+/trh- isolates was also used to screen all isolates.  No environmental isolates were 
positive for GS-PCR.  All 3 clinical tdh+/trh- isolates positively amplified using GS-PCR.  




 T3SS2β genes vscC2, vscS2, vopB2, and vopC were screened against all 158 
isolates.  Of the 30 tdh+/trh- strains, all tested negative for T3SS2β genes.  All 5 tdh-/trh+ 
strains tested positive for each T3SS2β genes.  No other isolate tested positive for T3SS2β 
genes (Table 2). 
All environmental strains in this study were isolated from the water column, 
sediment, or oyster meat (Figs. 1, 3).  
 
Figure 3.  The percent distribution of potentially pathogenic Vp. (A)  Distribution of 
isolates by hemolysin content over two separate sampling years.  (B)  Distribution of total 
isolates and of isolates in three environmental sources (oyster, water, and sediment).  (C)  
Distribution of isolates by sampling site.   
 
 Of 130 potentially pathogenic environmental strains isolated, 73 (56%) were 




of tdh+/trh- isolates in sediment, 19% from oyster samples, and 22% from water.  Out of 
100 tdh+/trh+ isolates, 54% were taken from sediment samples, while 22% and 24% were 
isolated from oyster and water respectively.  All 3 environmental tdh-/trh+ isolates were 
found in the sediment. 
The single local clinical strain, VPA2007-095, tested negative for both T3SS2 and 
GS-PCR and tested positive for tdh, trh, and T3SS1.  This result was also the most typical 
result for all 130 environmental strains that were screened. 
Discussion 
This study represents a rare look at the distribution of a poorly understood 
community of naturally-occurring bacteria from which human pathogens can arise.   
Although the great majority of infections come from Vp isolates containing tdh and/or trh 
and epidemiological evidence has correlated the two gene products (hemolysins) with 
pathogenicity (29), almost all naturally-occurring (environmental) isolates lack these two 
hemolysins (72, 73).  Therefore, human infections most commonly arise from rare, 
naturally occurring tdh+ and/or trh+ Vp strains found in finfish, shellfish, coastal waters 
and sediment.    On average, during the 2007 sampling period tdh- and trh- positive 
isolates represented 3% and 1% of the total (tlh+) environmental Vp detected in this study, 
respectively (7).    We were able to acquire a large pool of potential pathogens (tdh+ and/or 
trh+) by enriching environmental samples and isolating individual colonies that contained 
either tdh or trh.  Each enriched sample plate yielded anywhere from 1-10 colonies 
containing tdh and/or trh with an average of less than 2 colonies per plate.  Several 
colonies from the collection were analyzed for genetic diversity using REP-PCR and 
MLSA data (31) including several suspected duplicate colonies.  Two sets of isolates were 




Vp2007-047.  Interestingly, the data from this paper also showed that colonies containing 
tdh and/or trh from the same plate did not necessarily have the same genetic fingerprint or 
allelic profile, thus colonies coming from the same plate could not be dismissed as 
identical strains. 
The genetic compliment in Vibrio greatly affects their function in nature (67).  
Several Vp pathogenicity factors have been discovered, including TDH, TRH, urease, and 
pili (3, 27, 74, 75).  The presence of other pathogenicity factors such as the T3SS may alter 
a bacteria’s fitness or ability to colonize certain environments such as host organisms 
including oysters.  Since the Gulf of Mexico is the major producer of oysters used for raw 
consumption in the United States (76), this possibility has public health implications.  
However, our data shows a similar distribution between oyster, water, and sediment 
regardless of the presence of hemolysins or T3SSs (Figure 3).  The only exception to this 
has been with tdh-/trh+ isolates which were found only in sediment.   
Only three tdh-/trh+ isolates were identified throughout the sampling period and all 
three isolates were found in the sediment at sampling site MS6 (Figs 1, 3).  The 
temperature and salinity of site MS6 at the time each of the 3 tdh-/trh+ isolates were 
collected were not significantly different from other sampling sites.  Although there does 
indeed appear to be a bias as to at which site tdh-/trh+ isolates were found,  temperature and 
salinity do not appear to be major factors; further investigation of  site MS6 may better 
explain this isolate collection anomally. 
In a separate study it was demonstrated that Vp outnumbered V. vulnificus in the 
sediment but not in oysters or in the water column (C.N. Johnson, mss in prep).  Turbidity 
also played a large role in the densities of Vp and the sediment.  Both suggest that sediment 




   This study examined the distribution and variation of T3SS in Vp.  Genes were 
selected based on relative necessity/function of the related protein in the secretion system, 
physical distribution in the T3SS gene cluster, and fidelity across the genome.  In the case 
of T3SS2β, genes were chosen based on homology to T3SS2α genes that were also 
targeted in this screening.  Three of the four T3SS2β genes screened have a homologous 
T3SS2α gene which was also screened: vscC2, vscS2, and vopB2, with 70%, 74%, and 
70% homology, respectively.  All 158 isolates tested positive for all 5 T3SS1 genes, 
confirming earlier reports of T3SS1 being ubiquitous in Vp (23, 54).  T3SS2α, which has 
been shown to correspond with tdh+/trh- strains (34, 54), was found in all 30 tdh+/trh- 
samples, regardless of whether that isolate was GS-PCR positive.  No other isolates tested 
positive for any of the five T3SS2α genes present in the screen.  The discovery of a T3SS2 
variant, T3SS2β, was made relatively recently (58) and has been confirmed in this study as 
being present in 5/5 tdh-/trh+ isolates.  To our knowledge this is the first reported case of 
T3SS2β genes identified in Vp from the Gulf of Mexico.  
While most Vp serotypes are noninfectious, the few infectious serotypes can 
become major agents of outbreaks worldwide (24, 34).  In 1996, a pandemic strain was 
discovered in Calcutta and was described as a “new” O3:K6 type strain that was different 
from previously described clones and carried tdh but not trh (28). Ample evidence has 
linked tdh+/trh- strains of Vp with pandemic-causing serotypes (18, 28, 41, 47, 77).  We 
have reported that roughly 20% of all potentially pathogenic isolates collected in this 
experiment were tdh+/trh-; we screened 158 isolates using GS-PCR (41) for identification 
of any isolates belonging to the pandemic-causing group.  Out of 27 environmental 
tdh+/trh- isolates, none tested positive for GS-PCR.  However, all three clinical tdh+/trh- 




the FDA (Table 1).  No other isolate, environmental or clinical, tested positive for the 
toxRS amplicon, including the single local clinical isolate.  The non-amplification of GS-
PCR on the local clinical isolate is not surprising as there have been no reported cases of 
the pandemic clone, O3:K6, being found in the Gulf of Mexico.  Unsurprisingly all 
environmental isolates tested negative for GS-PCR as well.   
Aside from variations between the overall T3SS2 gene cluster, not all individual 
genes identified as part of the Vp T3SS2 have been found in all isolates, allowing for some 
minor intra-species variation.  VPA1362, an orf encoding the effector protein VopB2 in 
T3SS2α, was found in this study to be absent from all environmental tdh+/trh- isolates and 
present in all clinical tdh+/trh- strains.  The gene vopB2 was the only gene to be present 
differentially between environmental and clinical strains.  The absence of vopB2 in 
environmental strains appears to be specific to the T3SS2α variant.  The T3SS2β vopB2 
gene variant (73% homology to T3SS2α VPA1362) was found in all tdh-/trh+ isolates, not 
only clinical strains.   
All four T3SS2β genes targeted in this screen were positive in all five tdh-/trh+ 
isolates.  This confirms the previous report of T3SS2β being found in tdh-/trh+ strains. The 
T3SS2β variant was recently discovered by Okada et al (58) and other T3SS2-related 
genes have been reported (78). The history of genetic transfer of T3SS in Vp is not well 
understood but the fidelity between hemolysin content and type of T3SS was observed in 
this experiment.  Instinctively this makes sense as T3SS2β was shown to be near trh in the 
genome, while genetically T3SS2α is flanked by tdh.   
The majority of potential pathogens we observed in this study were positive for 
both tdh and trh.  All of these isolates tested negative for both T3SS2α and T3SS2β.  This 




using sequences solely from tdh+/trh- and tdh-/trh+ isolates.  A third T3SS2 variant may 
reside in tdh+/trh+ isolates, yet be undetected due to significant sequence divergence.  A 
clear example of this came in 2009 when T3SS2β was discovered in strains thought to be 
lacking a T3SS2, although T3SS2α sequences had been known for 6 years.  In order to 
compensate for lack of sequenced Vp genomes, future studies may include adapting RING-
FISH to target typical T3SS2 genes in Vp and screening isolates using a less stringent 
annealing method in order to detect homologues with moderate similarity. 
 Currently, the pathogenicity island on chromosome 2 of Vp in which the T3SS2 is 
located has been demonstrated to contain either tdh and T3SS2α or trh and T3SS2β, but 
not both sets. There is currently a lack of genetic sequence data for strains containing both 
tdh and trh.  However, understanding the genetic structure of the pathogenicity island in 
tdh+/trh+ strains may be important as we have observed these strains to make up a large 
portion of the environmental “potentially pathogenic” isolates.  
In addition to lack of knowledge about tdh+/trh+ isolates, tdh-/trh- isolates also have 
not been well characterized, although they make up the vast majority of environmental Vp 
isolates.  In one report, four T3SS2-related genes were found to exist in non-toxigenic 
strains and were found to be actively transcribed (78).  Although our results contradict 
those reported by Caburlotto et al. (78), it is difficult to hypothesize why these differences 
occurred. For instance, Caburlotto et al. examined Vp in the Venetian Lagoon while this 
study examined populations in the Gulf of Mexico, vastly separate areas with differing 
environmental conditions.  Little is known about the genetic distribution of spatially 
separated Vp populations.  Although we have not observed T3SS2 genes in any of our tdh-
/trh- isolates, additional strains from the northern Gulf of Mexico are being gathered for 




 In conclusion, our study has taken advantage of a unique opportunity provided by 
a large collection of potentially pathogenic environmental isolates to examine the presence 
of T3SS variation in Vp.  We have reinforced the observation that T3SS1 is present in all 
Vp strains.  Furthermore, the presence of T3SS2α, which has been most frequently 
associated with pathogenic Vp, was shown to coexist with tdh but was absent from all 
isolates containing trh in this study, confirming previous reports from other regions in the 
world.  T3SS2β was detected in all tdh-/trh+ isolates, suggesting the two versions of T3SS 
are exclusive to their respective hemolysin profile and also confirmed the presence of 
T3SS2β in tdh-/trh+ isolates.  As more information is discovered about the presence and 
distribution of pathogenicity factors like the T3SS in Vp, analysis of natural populations 
should be used to better understand the relationship between genetic content and diversity 
in the environment. 
About This Chapter 
The work in this chapter was published March 2010 in the Journal of Applied 






VARIATION IN SURIVIVAL RATES OF POTENTIALLY VIRULENT V. 
PARAHAEMOLYTICUS EXPOSED TO OYSTER HEMOCYTE 
The presence of virulence factors such as tdh, trh, and the T3SSs have been shown 
to have a significant effect on Vp pathogenesis in humans (79, 80). It remains unclear what 
role these factors have in host immune system avoidance for Vp residing in oyster tissue or 
in other marine animal tissues.  In this experiment, we collected and typed 28 non-
homologous Vp strains and challenged them with oyster (C. virginica) hemocyte 
bactericidal assays.  Isolates were screened in parallel for the presence of tdh, trh, T3SS1, 
T3SS2α, and T3SS2β and sorted into pathogen sub-groups based on the presence of 
hemolysins tdh and trh.  Hemocyte-induced bactericidal activity, through a calculated 
Hemocyte Killing Index (KI), was compared between pathogen sub-groups  to determine if 
virulence factors have any influence.  
              Caco-2 cells, a human adenocarcinoma cell line, were also challenged with 
specific strains of Vp used in this experiment to determine if any relationship existed 
between toxicity in human intestinal epithelial cells and the presence of virulence factors. 
Variations in Vp cytotoxicity were analyzed between pathogen sub-groups and compared 
with Vp abilty to avoid killing by oyster hemocytes. 
Materials and Methods 
Bacterial Strain Isolation. Beginning in August 2007, water, oyster, and sediment 
samples were collected in four sites in the Mississippi Sound and transported on ice 
immediately to the laboratory for bacterial isolation.  Vp isolates were identified using a 
direct plating/colony hybridization method described previously (7) with markers for tlh, 




confirmed.  Each isolate was then screened for T3SS1, T3SS2α, and T3SS2β using PCR 
(Appendix A).  These screens were performed using three separate multiplex reactions 
targeting a total of 12 genes with gene-specific primers.  All PCR primers, with the 
exception of those targeting T3SS2β, were original and designed to produce amplicons of 
distinct separate sizes(59). After each isolate was characterized for the presence of 
virulence factors tdh, trh, T3SS1, T3SS2α, and T3SS2β, they were checked on non-
specific T1N3 agar plates for contamination. For long-term storage, all cultures were 
placed in T1N3 agar deeps with oil. For short-term use over the course of this study, 
cultures were taken from long-term storage, grown on T1N3 agar plates at room 
temperature, and placed in a 12oC environment to slow growth. When needed, the agar 
plates were taken from 12oC and allowed to warm up to room temperature. 
Preparation of Vp strains, hemocytes, and Caco-2 cells for cytotoxicity challenges. 
A total of 28 strains were tested in oyster hemocyte bactericidal assays. All strains tested 
can be found in Appendix B. Individual colonies were picked and grown overnight at 37oC 
in 15mL of APW for cytotoxicity challenges. Pure Vp cultures grown this way and 
sampled the next day contained an average density of 3-4x107 cells ml-1 (data not shown). 
After overnight growth, cells were pelletted at 3000g for 5 minutes and washed twice with 
PBS. Cells were re-spun after wash and re-suspended in sterile PBS at the appropriate 
volume to achieve final seed dilution of 1x105 cells per challenge. Bacterial seed densities 
remained constant in both oyster hemocyte and Caco-2 cytotoxicity challenges. 
             Eastern oysters (Crassostrea virginica) were gathered from the same sample sites 
where Vp was collected (Figure 1, pg 9). Oysters were transported on ice to the lab where 
they were immediately sacrificed for hemolymph.  Specifically, a ½” notch was made with 




sterilized glass syringe fitted with a 23 gauge needle was inserted into the adductor muscle 
and hemolymph was drawn out and placed in polystyrene tubes on ice to prevent 
clumping. Care was taken not to draw mantle fluid in. The total time from oyster shell 
notching to hemocyte extraction was approximately 90 seconds for each oyster. The 
required volume of hemocyte needed for each 96-well challenge plate was pooled from 8-
15 oysters.  After hemocyte collection, a hemocytometer was used to determine densities 
and hemocyte concentration was adjusted to ~2x105 cells ml-1. A dye exclusion assay was 
performed by diluting a subsample of hemolymph 1:5 with a 0.4% Trypan Blue solution. 
Hemolymph was then observed under a light microscope (Zeiss) to confirm presence and 
viability of hemocytes 
 Caco-2 cells, acquired from the American Type Culture Collection (ATCC) were 
grown in culture flasks (Falcon) containing Eagles Minimum Essential Media (EMEM) 
with 20% Fetal Bovine Serum (FBS) at 37oC in 5% CO2. No antibiotics were used in 
Caco-2 culture. Cells were passed 1-2x per week.  Vp toxicity challenges took place 
between passages 8-15.  
Cytotoxicity challenges. All Vp cytotoxicity challenges were based on previously 
published hemocyte and Caco-2 killing assays (81-85). Each Vp strain involved in a 
cytotoxicity assay was tested in triplicate. Assays were done using 96 well plate flat 
bottomed plates (Falcon). Each plate seeded with ~1x104 oyster hemocyte or Caco-2 cells 
per appropriate well. Sterile artificial seawater (ASW) was used as the media in hemocyte 
challenges, while EMEM was used in Caco-2 challenges. In hemocyte cytotoxicity trials, 
each plate was spun down at 180g for 10 minutes prior to addition of Vp to promote 
hemocyte attachment. Oyster plasma was then removed and replaced with PBS. 1x105 Vp 




10. This MOI was chosen based on previous Vp cytotoxicity work (82-84). After addition 
of both hemocyte/Caco-2 and Vp cells, each plate was spun down (Eppendorf 5430R) at 
4oC and 160g for 10 minutes to promote Vp attachment. 
Hemocyte cytotoxicity challenges were placed at room temperature (20oC) and 
incubated for 5 hours. Caco-2 cytotoxicity challenges were incubated at 37oC and 5% CO2 
for 5 hours.  
Cytotoxicity was measured via 3-(4,5-Dimethylthiazol-y-yl) (MTT) assay, which 
measures cell viability by assessing mitochondrial activity through colorimetric analysis of 
a reduced formazan dye end product. Specifically, a clear chemical product is added to the 
well. Active mitochondria convert this colorless product into an insoluble dye, which 
precipitates out to give a purple color. A relationship can be established between dye 
absorbance and cell density, thus providing an estimate for cell viability. Twenty five uL 
of APW was added to each well along with the MTT compound after incubation. An 
additional 2 hour grow-out/recovery period was provided after which the challenge was 
stopped using a solubilization solution.  After dye solubilization, each plate was read at 
570nm and 725nm absorbance using a SpectraMax M2 plate reader (Molecular Systems). 
The KI and % bacterial survival in oyster hemocyte cytotoxicity challenges were 
calculated using the following formulas (85): 
Oyster Hemocyte KI = 1 – [ (AbsHB – AbsH)/ AbsB] 
 
% Vp Survival = 100* (1- KI) 
 
The cytotoxicity of Vp to Caco-2 cells was calculated with the following formula: 










 A total of 29 strains of Vp were tested for the ability to survive exposure to oyster 
hemocytes. Nine tdh+/trh+, nine tdh+/trh-, four tdh-/trh+ , and six tdh-/trh+  Vp strains were 
tested. The hemocyte survival % +/- Standard Deviation (SD) was 43.6 +/- 21.8, 51.7 +/- 
21.9, 47.2 +/- 10.1, and 58.7 +/- 14.6 for tdh+/trh+, tdh+/trh-, tdh-/trh+ , and tdh-/trh+ , 
respectively (Table 4, Figure 4).  
Table 4 
 
Vp survival in Oyster Hemocyte 
 
 
tdh/trh  Sum  n Avg Survival(%) Std Dev Std Error 
 
 
+/+  508.161 9 43.538   21.846  7.282 
 
+/-  435.145 9 51.651   21.864  7.288 
 
-/+  211.173 5 47.207   10.096  5.048 
 







Figure 4. The percentage of Vp cells still viable after 4 hour oyster hemocyte bactericidal 
assays, separated by potential pathogen subgroup. Standard error bars are shown. 
 
Twenty-five strains of Vp were additionally tested for their respective cytotoxic 
potential when exposed to Caco-2 cells (Table 4, Figure 5). Caco-2 Cytotoxicity was 
defined as the percentage of Caco-2 cells still alive after a four-hour exposure to an 
individual Vp strain. Caco-2 cytotoxicity +/- SD was measured at 56.7 +/-13.1, 56.17 +/- 




Percentage of Caco-2 cell death after exposure to Vp 
 
 
tdh / trh Sum  n Avg Kill %  Std Dev Std Error 
 
 






Tabled 4 (continued). 
 
 
+/-  337.0  6 56.17   29.451  12.023 
 
-/+  128.0  5 25.60   20.256  9.059 
 





Figure 5.  The percentage of Caco-2 cells killed after a 4 hour Vp-Caco-2 cytotoxicity 
assay. Standard error bars are shown. 
 
A student’s t-test (α = 0.05) was used to evaluate any significant differences in 
oyster hemocyte survival between potential pathogen subgroups (Table 6). Potential 
pathogen subgroups were also tested for significant differences in cytotoxicity of Caco-2 






Student t-test p values for Vp virulence factor sub-group comparisons in oyster hemocyte 
bactericidal assays  
 
 
 (tdh/trh) +/+  +/-  -/+  -/- 
 
+/+  -  0.539  0.929  0.471 
+/-  -  -  0.538  0.972   
-/+  -  -  -  0.446 
 
Table 7 




(tdh/trh) +/+  +/-  -/+  -/- 
 
+/+  -  0.569  0.0119* 0.295  
+/-  -  -  0.092  0.552     
Table 4B (Continued). 
-/+  -  -  -  0.386 
*Significant Difference at α=0.05 
No meaningful relationships between presence of virulence factors and ability to 
survive oyster hemocyte killing were observed. There was a significant difference in Vp 
survival rates between strains of clinical and environmental sources (p=0.028, α = 0.05), 




between environmental and clinical strains of Vp during Caco-2 exposures (p=0.80 α = 
0.05). 
 One potential pathogen subgroup, tdh-/trh+, displayed significantly different 
cytotoxicity in Caco-2 assays than the tdh+/trh+ subgroup (p value 0.0119). While 
insignificant, a p-value of 0.092 was found in a comparison of tdh-/trh+ and tdh+/trh- 
subgroups for cytotoxicity in Caco-2 assays. 
 Not all strains of Vp tested for oyster hemocyte survival were tested for Caco-2 
cytotoxicity due to logistical and technical difficulties. Each of the strains tested for Caco-2 
cytotoxicity had been previously tested for oyster hemocyte avoidance. No strains were 
tested for Caco-2 cytotoxicity that had not been previously challenged for a hemocyte KI. 
 There was a loose negative correlation between Caco-2 cytotoxicity and oyster 
hemocyte killing avoidance with an r value of -0.43. Vp strains with varying presence of 
virulence factors tdh, trh, and T3SS2 variants α and β did not contribute differently to 
bacteria exposed to oyster hemocyte or Caco-2 cells with one exception (tdh-/trh+ 
subgroup in Caco-2 cytotoxicity tests). 
Discussion 
The use of a reduced dye compound to measure Vp bactericidal activity in oyster 
hemocyte has been well documented (82, 85) and provides a reliable mechanism to study 
bacterial responses to immunological activity in vitro. The results of C. virginica hemocyte 
bactericidal activity in this study correlated with previous published reports of tests on 
some of the same clinical Vp strains as tested in this experiment (82, 86). The majority of 
Vp strains used in these challenges were environmental isolates and therefore unique to this 




examined. In the current experiment, Tx2103 was found to have a hemocyte KI of 55%, 
whereas previous reports displayed a KI of ~52% for the same strain (86).  
The correlation of virulence factors in bacterial species and their fate after exposure 
to oyster hemocyte has been studied but is still not well understood (85-88). Reports 
indicated that Vp  hemocyte  bactericidal activity was correlated with season (82) and the 
nature of the strain (environmental vs clinical) (86). In this experiment, all oysters 
collected for hemocyte exposure were done between July and August of 2010. Mean water 
temperatures did not vary significantly to affect hemocyte activity, although the high 
summer temperatures could have provided an increased bactericidal activity as previously 
reported (82). 
Both environmental and clinical strains were tested in this experiment, including 
one local clinical isolate, Vp2007-095JW. Each virulence factor subgroup tested contained 
at least one clinical and environmental sample. A list of all strains tested can be found in 
Appendix B.  
Caco-2 human intestinal epithelial cells were chosen to investigate the cytotoxic 
ability of Vp. Specifically, Caco-2 cells were chosen because these cells differentiate into 
intestinal epithelial cells (89) when grown to confluence and express the appropriate 
intestinal epithelial membrane proteins. Previous studies of Vp cytotoxicity have been 
performed using Caco-2 cells as a reliable and practical in vitro cytotoxicity assay (62, 80, 
84, 90-92). All Caco-2 cultures used in cytotoxicity assays were harvested after a 
minimum of 8 passes, thereby assuring the development of epithelial tight junctions and 
appropriate display of surface antigens (93) in the culture monolayer.  
In both oyster and Caco-2 assays, potential pathogen sub-groups did not display 




cytotoxicity of tdh-/trh+ and tdh+/trh+ isolates (p= 0.012). The average Caco-2 killing 
capacity of strains in these two virulence factor sub-groups was 19.8% and 58.5%, 
respectively. These results indicate that tdh-/trh+ isolates could be less effective; however, 
even though the results were statistically significant the data set is too small to provide a 
conclusive association. Over a period of four years, we were only able to isolate three 
environmental tdh-/trh+ isolates. The reason behind the rarity of these isolates in the 
northern Gulf of Mexico is not well understood and acts as a natural limit on statistical 
analysis in this experiment. 
The oyster hemocyte bactericidal assay data indicated that there was significant 
interstrain variance with regards to survival in bactericidal conditions. No differences 
could be seen by separating out the strains via potential pathogen sub group. Similar trends 
were seen in the Vp-Caco-2 cytotoxicity assays.  
Overall, there was a weak negative correlation (r= -0.43) between Vp cytotoxicity 
in Caco-2 cells and survival in oyster hemocyte exposures. However, the significance of 
this correlation must take into account the experimental models. Caco-2 cytotoxicity 
assays, by necessity, take place in a media rich cell-culture environment widely different 
from the environment found in oyster hemocyte assays. Furthermore, Caco-2 assays only 
function as a model for cytotoxicity, the assays are significantly different from the 
environment of the human gut.  
Interactions between tissue (hemocyte or Caco-2 monolayer) and Vp cells also 
occur in each experimental assay and may affect results. Many virulence factors in Vp such 
as T3SS1 and T3SS2 may be differentially expressed under various environmental 




Signaling processes controlling large genetic systems may take more time than 
available in these assays and is a limiting consideration for this type of experiment. For 
instance, Vp transitions between growth in a liquid medium (swimmer) and growth on a 
surface (swarmer) by shifting expression profiles of key genes such as the polar flagellum 
(96-99). These transcriptomic shifts are also responsible for the expression and repression 
of some virulence and secretion genes (100).  
The bactericidal and cytotoxicity assays in this report were done over a four hour 
time course, as determined by preliminary MTT data (not shown) and previously published 
experiments (82, 84, 101). This experiment allows for good short-term standardized data to 
be gathered for Vp immune-avoidance by controlling bacterial starting densities, tissue 
densities, and total exposure time, but sacrifices the depth and detail of a microcosm-type 
experiment. Future research using microcosms and long-term (multiple week) exposures to 
oysters could illicit a more complete understanding of the relationship between virulence 






TRANSCRIPTIONAL REGULATION IN POTENTIALLY VIRULENT V. 
PARAHAEMOLYTICUS DURING EXPOSURE TO INTESTINAL EPITHELIAL CELLS 
AND OYSTER HEMOLYMPH 
 The presence and absence of specific genes in environmental and clinical Vp strains 
have been well studied, while genetic expression studies of Vp are much more uncommon 
in the current literature. The study of gene expression can be prohibitive for a number of 
reasons including cost and quality of experimental design. Of the gene expression studies 
in Vp that have been reported, the majority have been performed on specific targeted 
subsets of genes (94, 102-108). Few genome-wide Vp studies have been done (109, 110). 
 This study examined the genetic expression differences between groups of 
pathogenic, potentially virulent clinical Vp strains using whole genome DNA microarrays. 
Specifically, two clinical Vp strains representative of distinct pathogenic subgroups were 
challenged with Caco-2 human intestinal epithelial cells and oyster hemolymph over a four 
hour exposure. The purpose of this study was to identify genes significantly differentially 
expressed in potentially virulent strains of Vp over time and between pathogenic groups. 
Understanding the role of potentially virulent bacteria in the environment is a key 
step in discerning the relationship between these organisms and public health risk. It has 
been well documented that the vast majority of clinical Vp cases involve strains represent 
only a small portion of the overall Vp community in the environment (7, 8, 73). A recent 
survey in the northern Gulf of Mexico indicated roughly 4-5% of Vp isolates sampled 
contained relevant virulence factors (31). Furthermore, this study indicated that the 




only in the sediment. Current similar studies continue to show such patterns in potentially 
virulent Vp (Johnson 2012, mss in prep).  
We chose to study the regulation of genes involved with Vp exposure to oyster 
hemolymph by analyzing bacterial transcriptomic responses over time. Vp is found 
naturally in oyster tissue, yet the relationship between potentially virulent Vp and oyster 
colonization is unclear, if indeed they colonize oyster tissue. It is possible that Vp exists 
transiently in oysters. Multiple experiments have shown that Vp is depurated at varying 
rates in molluscs including oysters, but do not completely rid themselves of Vp (111-113). 
By analyzing the expression responses in potentially virulent Vp exposed to oyster 
hemolymph, a relationship between genetic capability and environmental functionality 
could be elucidated.    Furthermore, we chose to corroborate thesis data with expression 
data gathered from Vp exposure to Caco-2 adenocarcinoma cells. Caco-2 cells, once grown 
to confluence, differentiate in to human intestinal epithelial cells. Both oyster hemolymph 
and Caco-2 exposure designs provide basic in-vitro mechanisms for understanding 
complex in-vivo functions. 
Materials and Methods 
Bacterial Strains. Two Vp strains, TX2103 and AQ4037 were chosen for this study 
as representatives of the pathogen subgroups tdh+/trh-/T3SS2α+ and tdh-/trh+/T3SS2β +. 
The two Vp strains chosen are the FDA reference strains used for potentially virulent 
subgroups. AQ4037 is the strain in which TRH was originally discovered (27). It should 
also be noted that Tx2103 belongs to the pandemic O3:K6 serovar, while AQ4037 is of the 
non-pandemic (or pre-pandemic) O3:K6 serovar. The presence of tdh, trh, and T3SS genes 
was confirmed using gene-specific PCR (Table 2, pg 14). All strains were acquired from 




 Strains were kept on T1N3 agar deeps at room temperature for long term storage 
and T1N3 plates at 15oC for short-term storage. Cultures were re-plated every four weeks 
and examined for contamination. For microarray analysis, cultures were removed from 
short-term storage and individual colonies were plated onto Thio-Citrate-Bile-Salt (TCBS) 
agar plates and incubated at 37oC overnight. After confirmation on TCBS plates, colonies 
for each strain were placed into 15mL 10X Alkaline Peptone Water (APW) and grown for 
18 hours at 37oC. Cultures were then enumerated using both plate count and 
hemocytometer. The procedure of inoculating in APW through enumeration was repeated 
multiple times to ensure consistent and reproducible bacterial concentrations for each 
strain. 
 Prior to gene expression challenges, each strain was grown overnight in 10X APW 
at 37oC. Afterwards, the cultures were pelletted by centrifugation at 2200g for 10 minutes 
followed by removal of the growth media. Cells were then washed with Phosphate 
Buffered Saline (PBS) and respun. After this, Vp pellets were resuspended in PBS and 
diluted 1:5 for a final concentration of 1.1x106ml-1. This concentration was chosen to give 
a Multiplicity of Infection (MOI) of 10 in the challenges. 
Caco-2 culture. For genetic expression analysis Vp was challenged with both Caco-
2 colorectal adenocarcinoma cells and oyster hemocyte. Caco-2 cells display 
characteristics of enterocytic differentiation once they have reached confluence and were 
acquired from the American Type Culture Collection (ATCC). The cells were grown in 
Eagles Minimum Essential Media (EMEM) (ATCC) with 20% Fetal Bovine Serum 
(FBS)(ATCC) at 37oC in 5% CO2.  Cells were passed two times per week at roughly 80% 
confluence. All Vp toxicity challenges took place between passages 8-15.  For Vp 




with trypsinized Caco-2 cells. The doubling time for Caco-2 cells is approximately 62 
hours; prior to inoculation, the cell concentration was checked with a hemocytometer. 
Once the concentration was known, each flask was seeded with an initial concentration of 
~2.5x104mL-1 cells per flask with the objective of reaching a final concentration of 
1x105mL-1 cells in a confluent layer, thus achieving the stated MOI of 10.  
Collection of oyster hemolymph. Acquisition of a large volume of oyster 
hemolymph was accomplished by harvesting Crassostrea virginica oysters directly from 
the environment. Specifically, all oysters were collected locally in areas identical to where 
local Vp were acquired (see Chapter 2). Once oysters were collected, oyster hemolymph 
was pooled from multiple oysters and placed immediately on ice to prevent cell 
aggregation. Specifically, oyster hemolymph was extracted as previously described (81)(K. 
Burnette, personal correspondence)  with some modifications. Specifically, oysters were 
notched on the posterior edge with a pair of sterilized pliers.  Next, a sterile glass syringe 
with a 23gauge sterile needle was inserted through the cavity and into the adductor muscle. 
Hemolymph was drawn directly from the adductor muscle, with great care taken not to 
extract mantle fluid as well.  Consistent with previous reports, roughly 1-5 ml of 
hemolymph were collected per oyster (81, 82).  After hemolymph was collected and 
pooled together on ice, hemolymph concentrations were measured using a hemocytometer 
and diluted with sterile ASW to 1 x 105 ml-1.  Cell enumeration was performed as 
described previously (114) using hemocytometry to determine viable cells using dye 
exclusion.  Trypan blue, chosen for dye exclusion, was combined with hemolymph 
suspension and injected into a hemocytometer.  All stained and unstained cells were 




Bacterial Challenges. To determine levels of Vp gene expression during exposure 
to various tissue types, two representative Vp strains were challenged with two differing 
tissue types: oyster hemolymph and Caco-2 cells. The experiment was comprised of 32 
separate challenges; each bacterial strain was challenged with each tissue type at two 
separate time points, 1 hour and 4 hours. These time points were chosen based on 
preliminary growth data with media only (Figure 6 and 7). 
 









 Each challenge (specific time point, strain, and tissue type) was repeated in 
quadruplicate to ensure reproducibility and to identify any irregularities in individual 
arrays. In oyster hemolymph challenges, the pooled and iced oyster hemolymph was 
enumerated and seeded into 6 well culture plates (BD Falcon) as previously described (82) 
with slight modification. Specifically, 3 x 105 hemocyte cells (3mL of 1x105) were seeded 
per well and spun down for 10 minutes at 180g. Next the serous fluid was removed, the 
wells were washed with ASW, and the culture plates were respun. Finally, the ASW was 
removed and the correct volume of bacteria (3mL of 1x106) was added to achieve a final 
MOI of 10. The culture plates were respun a final time for 5 minutes at 180g to promote 
bacterial adhesion. At each time point (1 and 4 hours), half of the sample was carefully 
removed via pipette and immediately purified for RNA. 
Caco-2 challenges were performed with identical time points and MOI as the oyster 
hemocyte challenges to allow for inter-tissue time-point gene expression comparisons. 
Each of the 16 separate Caco-2 challenges was done in individual flasks where the human 
intestinal epithelial cells had reached confluence. Specifically, after flasks had reached 
confluence, Vp was added at the correction concentration and the flasks were spun down at 
180g for 5 minutes and placed back in 37oC 5% CO2 incubators. At each time point 
Vp/Caco-2 suspension was removed by pipette and immediately purified for RNA. 
RNA Extraction and Labeling. RNA taken from bacterial challenges was 
immediately stabilized with Qiagen RNAprotect and purified with Qiagen RNeasy mini kit 
as per the manufacturer’s suggested protocol (QIAGEN). After purification, RNA was 
checked on a NanoDrop 1000 (ThermoSci ) for concentration and contaminants. Once 
each RNA sample passed NanoDrop analysis, the sample was then loaded and run on a 




 After quality confirmation, each RNA sample was labeled for microarray analysis. 
RNA was labeled as per Pathogenic Functional Genomics Resource Center (PFGRC) 
instruction. Specifically, RNA was reverse transcribed using PowerScript RT (Invitrogen) 
in the presence of random hexamers and 25mM dNTP/aa-UTP labeling mix. The ratio of 
aa-UTP to dTTP was set at 2:1. Amino-allyl labeled cDNA was then purified using Qiagen 
MinElute (QIAGEN) kit, substituted a specific phosphate wash and elution buffer. After 
purification, the aa-cDNA was chemically labeled with a Cy3 dye ester and then repurified 
using the MinElute kit. Final analysis of the Cy3-labeled cDNA probe was done on a 
NanoDrop1000. Total dye incorporation and incorporation ratio was calculated. Probes 
were pelleted using a Vacu-fuge (Eppendorf) and stored short-term in the dark at -80oC 
until hybridization. 
DNA microarrays. The microarrays used were designed and produced by the J 
Craig Venter Institute (JCVI) 
http://pfgrc.jcvi.org/index.php/microarray/array_description/vibrio_parahaemolyticus/versi
on1.html). The JCVI produced these microarrays in the Pathogen Functional Genomics 
Resource Center (PFGRC) which was awarded to them by the National Institute of Health 
(NIH) National Institute of Allergy and Infectious Disease 
(http://www.niaid.nih.gov/Pages/default.aspx). The Vp microarray plates were awarded to 
this project after an application was submitted to the PFGRC. 
 The PFGRC microarrays used in this study correspond to the Vibrio 
parahaemolyticus v1 arrays. The design of the microarray is a standard glass slide with an 
aminosaline coating, printed with 21,168 spots distributed in 48 grids. The spots account 
for double-coverage of each of the 9,442 70mer oligonucleotides, along with controls. Vp 




and  plasmid pO3K6, and from V. cholera El Tor N16961. Annotation files are available 
for viewing at 
http://pfgrc.jcvi.org/index.php/microarray/array_description/vibrio_parahaemolyticus/versi
on1.html. 
 Microarrays were hybridized with Cy3 cDNA probes as per PFGRC instructions. 
Arrays were prehybridized with a 20xSSC/10%SDS/1%BSA solution at 42oC for one 
hour. Prehybridized slides were then washed, placed in alcohol, and dried extremely 
carefully to prevent streaks or spots on the array. The hybridization buffer used was a 40% 
formamide, 5xSSC, 0.1%SDS solution with 0.6ug/ul Salmon Sperm DNA added as a 
blocking agent. The hybridization buffer was then combined with the lyophilized probe 
and heated at 95oC for 10 minutes. Next, microarrays were hybridized using a a-Hyb 
hybridization station (Miltenyi) at 42oC for 20 hours. Array hybridization was limited to 4 
at one time. After hybridization, microarrays were washed and scanned using a VersArray 
scanner (BioRad). 
Expression Analysis. Analyses of scanned microarray images were done using the 
TM4 Microarray Software Suite (http://www.TM4.org). Specifically, Spotfinder v3.2.1 
was used for initial image analysis. Hybridized microarray images were received in dual 
layer TIFF format after scanning and loaded into Spotfinder. Next, grids were created 
semi-automatically using the listed PFGRC parameters and manually aligned to the array 
images. Spot intensities were determined using the Otsu segmentation method to subtract 
background noise. Annotation files were added, with the final Spotfinder analysis 
providing calculated intensities, background values, spot position/gene identifiers, and 




 Statistical analysis was accomplished using JMP Genomics software (SAS). After 
image analysis, data from Spotfinder was saved and loaded into JMP Genomics. 
Distribution analysis was accomplished for all 32 microarray files. After distribution 
analysis the data was standardized and a Correlation and Principal Components analysis 
was done. Normalization was then confirmed and significant differentially expressed genes 
were discovered using two-way Analysis of Variance (ANOVA). ANOVA was used to 
compare microarray data through inter-strain, inter-tissue, and time point comparison. 
 Minimizing the variance and noise of expression in microarray data sets is pivotal 
to making meaningful predictions. PFGRC Vp microarrays were designed with double 
coverage of all available probes. In this experiment, significant differentially expressed 
genes were recorded on a per-spot, not per-gene, basis. This was chosen to prevent under-
representation of significantly expressed genes through mechanisms such as physical 
sources of variation that occur spatially on the microarray. PFGRC arrays are spotted glass 
slides and therefore subject to variation from both the slide and printing apparatus. The 
application of a per-spot analysis along with quadruplicate biological replicates allows for 
the normalization of several sources of variance while at the same time emphasizing the 
identification of significant genes. 
Results 
The expression of the 9,442 genes gathered from each of the 32 Vp microarrays 
was analyzed using TM4 Microarray Suite and SAS JMP Genomics software. Each 
experimental sample was performed in quadruplicate to increase robustness of the results. 
The spot intensity levels for each array was normalized, grouped, and compared using a 
two-way ANOVA statistical test to predict up and down regulation of genes. Statistical 




types, as well as comparing the expression of genes between strains at identical time points 
and tissue type. No analysis was done to compare genetic expression between Caco-2 and 
oyster hemocyte challenge groups.  
In each strain, genes were identified as significantly up or down-regulated based on 
changes in levels of expression between the chosen time points of 1 to 4 hours. These time 
points were chosen after preliminary growth data (Figures 5A/B) demonstrated that once 
Vp cultures were seeded in their respective tissue type, Vp maintained a lag phase for 
roughly two hours before entering the exponential phase of growth. The initial time point 
of one hour was chosen to allow time for the bacteria to acclimate and gene expression 
reflect the environmental. The time point at 4 hours was chosen to prevent rising culture 
densities from shifting the MOI greatly and to also prevent the over-accumulation of 
degraded cells from having an effect on environmental chemistry such as pH, [CO2], [O2], 
etc. 
Regulation of genes in individual strains. A total of 475 genes were found to be 
significantly differentially expressed between time points for each strain in similar tissue 
challenges (Table 8).  
Table 8 
Summary of all genes significantly up or down-regulated in each Vp challenge group 
 
 Strain   Caco-2    Oyster Hemolymph 
 
   Up  Down   Up  Down 
 
Tx2103  39  24   80  72 





A list of all significant up or down-regulated genes can be found in (Appendix C). 
Over the course of the experiment in hemolymph tissue challenges Tx2103 significantly 
up-regulated 39 genes and down-regulated 24.  AQ4037 regulated (up/down) 35/31 genes. 
In Caco-2 tissue, Tx2103 significantly regulated (up/down) 80/72 genes over time, while 
AQ4037 contained 120/74 significantly regulated genes. 
Following identification of significant genes, functional categories for each of the 
significantly expressed genes was determined and genes were grouped according to 
specific function. The total number of genes in each category can be found in Figures 8 
and 9. 
 
Figure 8. Total genes regulated in Vp-oyster hemolymph challenges. Genes are separated 
into categories: Meta-Metabolism, Hypo-Hypothetical, Regulation, Trans/Sec- Transport 
and secretion related, Motility and Chemotaxis, Bio-Biofilm/attachment related, Vir-












TX AQ TX AQ TX AQ TX AQ TX AQ TX AQ TX AQ 
Metab Hypo Regulation Trans/Sec Motility Bio Vir 








Figure 9. Total genes regulated in Vp-Caco-2 challenges. Genes are separated into 
categories: Meta-Metabolism, Hypo-Hypothetical, Regulation, Trans/Sec- Transport and 
secretion related, Motility and Chemotaxis, Bio-Biofilm/attachment related, Vir-virulence 
related genes. 
 
 Functional categories consisted of metabolism (carbohydrate, lipid, amino acid, 
and nucleic acid), transport/secretion, motility/chemotaxis, regulatory proteins, 
hypothetical and conserved proteins, biofilm/attachment, and virulence-related genes. 
Generally, the number of genes up and down regulated over time in each category for 
individual strains was similar, with some exceptions. The ratio at which Tx2103 up-
regulated to down-regulated metabolic genes was 4.0 (16/4) in oyster tissue compared to 
AQ4037, which regulated metabolic genes at a ratio of 1.15 (15/13). This pattern was not 
observed in Caco-2 challenges where the ratio of up to down-regulated genes was 1.25 for 
Tx2103 and 1.85 for AQ4037. 
The majority of significant genes expressed over time for each strain took place in 
Caco-2 challenges (346) compared to oyster hemolymph (129). When separated by 
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Caco-2 challenges compared to oyster hemolymph challenges were 2.92, 2.625, 1.8, and 
2.5 for metabolism, hypothetical, regulation, transport/secretion, and chemotaxis, 
respectively. The ratio of total genes regulated in each tissue type was also separated by 
strain and category (Figures 10-12). 
 
Figure 10. Ratio of significantly up-regulated to down-regulated genes in oyster 
hemolymph challenges for each functional gene category and challenge type. Ratios are 
separated for each strain and gene functional group. Numbers greater than one indicate 
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Figure 11. Ratio of significantly up-regulated to down-regulated genes in Caco-2 
cytotoxicity challenges for each functional gene category and challenge type. Ratios are 
separated for each strain and gene functional group. Numbers greater than one indicate 
more up-regulated genes, numbers less than one indicate more down-regulated genes. 
 
 
Figure 12. Ratio of total number of genes expressed by strain (Tx2103/AQ4037). Numbers 
greater than one demonstrate more regulated genes in Tx2103, 1 means equal number of 
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Notably, in AQ4037 nine chemotaxis genes were regulated in Caco-2 challenges, 
while only one was regulated in oyster challenges. This is in contrast to the four genes 
regulated by Tx2103 in both oyster and Caco-2 challenges. 
The number of genes regulated in the hypothetical protein gene category varied 
significantly between challenge groups and strains. A ratio was determined by totaling the 
number of genes both up and down-regulated in each Vp strain for both challenge groups 
(Caco-2 and oyster hemocyte). The total number of significantly regulated genes in Caco-2 
challenge groups was divided by the total number of significantly regulated genes in oyster 
hemocyte challenge groups. The ratio of regulated genes in Caco-2 challenges to oyster 
hemolymph challenges was markedly in the hypothetical protein gene category. 
Specifically, the ratio in Tx2103 was 1.96 compared to 3.53 in AQ4037. In other terms, 
Tx2103 regulated twice as many hypothetical proteins in Caco-2 challenges, while 
AQ4037 significantly regulated almost four times the number of hypothetical genes in 
Caco-2 challenges than in oyster hemocyte challenges. The proportion of regulated 
hypothetical genes compared in all significantly regulated genes remained consistent 
between challenge groups, 31.0% and 30.3% for oyster and Caco-2 challenges 
respectively. 
No biofilm/attachment or virulence genes were detected as being significantly 
differentially expressed in oyster hemolymph challenges, however 11 total genes from 









Total genes up or down-regulated by category. O – Oyster, C – Caco-2  
  Metab Hypo Regulat Trans Chemo Bio Vir 




16 4 12 11 3 3 5 5 3 1 0 0 0 0 
AQ-
O 15 13 10 7 7 5 3 5 0 1 0 0 0 0 
Tx-
C 35 28 25 20 7 8 8 12 3 1 1 2 1 1 
AQ-
C 50 27 38 22 11 6 14 11 5 4 1 2 1 2 
 
Interstrain variation in expression of genes. A total of 523 genes were found to 
have significant interstrain variation at corresponding time points and tissue types (Table 
10).  
Table 10 
Total summary of genes displayed significant expression variation between strains at equal 
time points/challenge groups 
 
Metab Hypo Regul Trans Chemo Bio Vir 
 AQ TX AQ TX AQ TX AQ TX AQ TX AQ TX AQ TX 
Oys- 1h 5 23 2 9 0 1 1 4 2 0 0 0 0 0 
Oys - 4h 4 41 12 7 2 2 1 7 0 1 0 0 0 0 
Caco - 1h 19 34 21 19 5 10 5 8 3 2 2 0 3 5 




A total of 241 genes were expressed at a higher level in AQ 4037 across all time 
points and challenge groups while 282 genes were expressed at a significantly higher level 
in Tx2103. In oyster tissue challenges, Tx2103 contained 95 genes significantly higher 
expressed than AQ4037,while AQ4037 only expressed 29 genes at higher rates than 
Tx2103. These results are markedly different from the Caco-2 challenge where Tx2103 
displayed 187 genes at higher levels than AQ4037 and AQ4037 contained 212 genes that 
were expressed at significantly higher levels than Tx2103(Figure 13 and 14). 
 
 
Figure 13. Total number of genes significantly differentially expressed between strains at 
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Figure 14. Total number of genes significantly differentially expressed between strains at 
equal time points in Vp-Caco-2 challenges. 
 
Of the 241 genes expressed in higher amounts in AQ 4037, the vast majority (88%) 
came from the Caco-2 challenge group, while Tx2103 had only 66% (187) of genes from 
the Caco-2 challenge group. This discrepancy is most visible in the metabolism gene 
category. The ratio of metabolic genes expressed higher in Tx2103 to AQ4037 was 7.1 and 
0.85 in oyster hemolymph and Caco-2 challenge groups, respectively. The large 
discrepancy of genes expressed to higher degrees in Tx2103 to AQ4037 in oyster 
hemolymph can be further broken down by time point- at one hour the ratio was 4.6 while 
at four hours the ratiowas 10.25. The time point ratios in the Caco-2 challenge groups give 
almost the exact opposite effect, with the ratios of 1.79 and 0.60 for the one hour and four 
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Figure 15. Ratio of Tx2103 differentially up-regulated genes to AQ4037 differentially up-
regulated genes across all time points for each gene functional category. The challenge 




Figure 16. Ratio of Tx2103 differentially up-regulated genes to AQ4037 differentially up-
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Figure 17. Ratio of Tx2103 differentially up-regulated genes to AQ4037 differentially up-
regulated genes for each gene functional category in Caco-2 cytotoxicity assays. 
 
The disparity of strain expression ratios can be further seen in the 
transport/secretion gene category. In the oyster hemolymph challenge group, the ratio of 
transport and secretion genes expressed higher in Tx2103 compared to AQ4037 is 5.5, 
with ratios of 4.0 and 7.0 for the one and four hour time points, respectively. In the Caco-2 
challenge group, the ratio is 0.83 with one hour and four hour time points corresponding to 
the ratios 1.6 and 0.61. 
The largest disparities in significant gene expression between strains can be found 
in metabolism genes at the four hour oyster challenge time point (10.25) and virulence 
genes at the four hour Caco-2 challenge time point (7.0). Virulence genes were not 
significantly expressed between strains in any oyster challenge. In Caco-2 challenges, 
Tx2103 significantly expressed more virulence genes at the early time point (1.67 ratio) 
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This project was designed to gain a deeper understanding of how Vp differentially 
expresses genes between potential pathogen subgroups in a naturally- occurring extreme 
environment such as exposure to oyster hemocyte. The experimental design to acquire the 
RNA samples for analysis was based on previous oyster hemocyte bactericidal assays 
(Chapter III). There is currently little data available on Vp transcriptomic responses to 
oyster hemocyte.  
An identical experimental design to the oyster hemocyte bactericidal assay was set 
up based on Vp-Caco-2 cytotoxicity assays. The transcriptomic data gathered from Caco-2 
cytotoxicity experiments were used as points of comparison for hemocyte assays. 
Transcriptomic data from Vp in cytotoxicity assays is extremely useful when utilized as a 
comparison tool, but becomes much weaker as a stand-alone model when assessing Vp 
responses to environmental conditions. The Caco-2 models provide an excellent method 
for in vitro studies of bacterial cytotoxic potential but are not designed as a proxy for the 
human gut environment.  
The genetic cross-talk of tissues and bacteria must be taken into account when 
analyzing the Vp transcriptomic response in these assays. Mussel hemocytes regulate 
defense and immune-related genes at varying rates for different bacteria (115, 116). For 
instance, it has been demonstrated that hemocytes contribute to bactericidal activity 
through phagocytosis (117). Phagocytosis can be enhanced through the production of 
enzymes such as integrin and are well regulated in oyster hemocytes (118). It has also been 
demonstrated that different Vibrio species can cause different gene regulatory responses in 
mussel hemocyte (116, 119); however, the degree to which strains of a single species 




transcriptomic response of Vp in oyster hemocyte bactericidal assays was done recognizing 
the environmental variability caused by tissue ‘cross-talk’. The genetic regulation of oyster 
hemocyte was not studied in this experiment. Care was taken to normalize all hemocyte 
tissue samples. All hemolymph was pooled and maintained at an identical cold temperature 
to reduce clumping and promote uniformity during attachment. Oysters collected for 
hemocyte extraction were done on the same reef within a specific range of temperature and 
salinity. 
Caco-2 cells express genes which have a profound effect on Vibrio pathogenicity 
and virulence. Caco-2 cells differentiate into intestinal epithelial cells when grown to 
confluence in a monolayer and display multiple surface antigens. Several virulence factors, 
such as the T3SS, can cause multiple changes in gene regulation in target cells such as 
Caco-2 (37, 61, 62, 120-124). It has been previously reported that different potential 
pathogen subgroups contain differing T3SS (among other virulence factors) in Vp (59), 
therefore there may be differing  pathways of contribution to overall cytotoxicity. 
Mechanisms used by the T3SS can cause different and complex signaling cascades in 
Caco-2 cells, altering Caco-2 gene expression (120, 125, 126). Therefore, variance in 
genetic ‘feedback’ must be taken into account when interpreting interstrain Vp expression 
in Caco-2 cytotoxicity assays. 
Gene expression was measured by examining the differences in gene expression as 
opposed to analyzing the absolute transcriptomic response at each time point. Emphasis 
could be placed on those genes most likely effecting current environmental conditions by 
focusing on only genes which were up or down-regulated during an exposure. As such, 
there were a total of 475 genes identified as significantly up or down regulated in a 




being up-regulated. Neither strain was directly favored in identification of regulated genes 
over time, 45% of all regulated genes came from Tx2103 while AQ4037 comprised 55%. 
We found that the PFGRC Vp microarrays performed without showing bias. The JCVI 
PFGRC microarrays used in this experiment contained 70mer probes based on sequence 
data from available Vp genomes, which is limited and comprised mainly of the tdh+/trh- 
O3:K6 pandemic clone and variants thereof. Inherently, this could favor the Tx2103 strain. 
While both Tx2103 and AQ4037 are of the O3:K6 serovar, Tx2103 bears a closer genetic 
relationship to the pandemic clone RIMD2210633, as both are tdh+/trh-/T3SS2a+, while 
AQ4037 is tdh-/trh+/T3SS2B+. We found no evidence of this through analysis of available 
expression data. 
Metabolic differences in strains exposed to oyster hemocyte. The functional gene 
group Metabolic Processes contained the most number of genes in the oyster hemocyte 
bactericidal challenge groups with 37% of all regulated genes. In the hemocyte assays, 
Tx2103 and AQ4037 up-regulated a similar number of genes, 16 and 15 respectively. 
AQ4037 repressed metabolic genes at a significantly greater number of genes than 
Tx2103- 13 genes compared to 4.  
Tx2103 down-regulated a quinone and putative oxidoreductase, a DNA helicase 
ruvB, and a murein transglycolase. Quinone reductase has been demonstrated in Vp to be 
part of a respiration-driven sodium pump (127) that responds under alkaline conditions. 
Murein transglycolases alter the peptidoglycan layer of the cell during growth and 
development (128). AQ4037 down-regulated several genes involved in amino acid 
metabolism and synthesis, glycolysis, and DNA synthesis. The majority of metabolic 




Genes up-regulated by AQ4037 in the oyster hemolymph challenges included lipid 
metabolism and biosynthesis, ribosomal biosynthesis, electron transport, and several 
stress-related genes. Two siderophore synthesis genes were up-regulated, pvsA and an 
acsD homologue, suggesting Vp AQ4037 was operating under iron limiting conditions. 
PvsA is a vibrioferrin biosynthesis compound  synthesized under iron limiting conditions, 
while the acsD gene contains conserved domain sequences akin to the Erwinia 
acrhomobactin biosynthesis protein (129). A general stress resistance gene in E. coli, rpoS 
was up-regulated which induces a variety of genes including starvation genes (130). 
Carbon starvation is considered one of the primary inducers of RpoS (131, 132).  
Tx2103 up-regulated several metabolic genes involved in fatty acid metabolism 
and biosynthesis, lipid biosynthesis, and oxidative phosphorylation, but did not up-regulate 
any stress-related or starvation-induced genes. The discrepancy between down-regulated 
metabolic genes in Tx2103 and AQ4037 could be due to an increased level of fitness of 
tdh+/trh- potentially virulent Vp in oyster tissue. AQ4037 up-regulated several stress-
induced genes and siderophores. The majority of genes up-regulated by Tx2103 
corresponded to biosynthesis and metabolism. In a separate study of over four years, the 
presence of potentially virulent Vp in oysters from the northern Gulf of Mexico was 
examined. While several tdh+/trh+ and tdh+/trh- were cultured from oyster meat, no tdh-
/trh+ isolate was cultured from oyster tissue (31, 59). 
While Vp growth in preliminary experiments was very similar for each challenge 
group, we hypothesize that the diluted EMEM media in Caco-2 experiments could have 
provided nutrients and compounds unavailable to the Vp strains in the oyster hemolymph 
challenges. The cellular content of Caco-2 cells also differs from oyster hemocytes which 




2 and hemolymph challenges were run in separate distinct environmental conditions: Caco-
2 challenges were done at 37oC with 5% CO2 in diluted EMEM while oyster hemolymph 
challenges were done at 22oC in 18 ppt ASW with no media supplementation. For these 
reasons, there was no examination of differences in gene expression between tissue groups. 
The Caco-2 challenges presented contrasting metabolic expression data to the 
oyster hemolymph challenges. The Vp strain AQ4037 up-regulated twice as many 
metabolic genes as down-regulated. Tx2103 up-regulated several metabolic genes involved 
in DNA/RNA synthesis, stabilization, and repair as well as two genes coding for proteins 
involved in the breakdown of peptidoglycan. Alcohol dehydrogenase and glutathione 
peroxidase were also up-regulated, suggesting oxidative stress. Conversely, Tx2103 down-
regulated several genes involved in carbohydrate metabolism, biosynthesis, and electron 
transport. 
AQ4037 up-regulated a wide variety of metabolic genes including fatty acid 
synthesis and metabolism, sugar metabolism, RNA synthesis, and electron transport. 
Down-regulated genes included amino acid metabolism and biosynthesis, DNA repair and 
synthesis, sugar biosynthesis and metabolism, and a single heat-shock protein, related to 
DnaJ. 
Shifts in Patterns of Localized Hypothetical Gene Expression in Vp-Oyster 
Hemocyte Assays. A total of 145 hypothetical and conserved genes were significantly up or 
down-regulated over time in both Caco-2 and oyster hemocyte assays. Combining data 
from both strains, more hypothetical genes were up-regulated in Caco-2 challenges (72%) 
than in oyster challenges. Some of the hypothetical genes were found to have metabolism-
related conserved domains which could partly explain why hypothetical genes were 




Vp contains two chromosomes of 3.29Mbp (I) and 1.88Mbp (II). Both 
chromosomes contain an identical percentage of protein coding regions with nearly 
identical average coding length (23). Chromosome I contains most of the essential growth 
and viability genes including copies of each tRNA gene; chromosome II contains some 
essential genes and genes related to regulation and transport. Chromosome II is considered 
to have a role in environmental adaptation (23).  
In the oyster hemolymph challenges, Tx2103 significantly regulated more genes on 
chromosome II than AQ4037 in oyster hemolymph (13 to 2), but not in Caco-2 cells (23 to 
34). Since chromosome II has been related more to environmental adaptation, these 
hypothetical proteins could be involved in pathways which helps Tx2103 adapt to the 
oyster environment. Both strains regulated a similar relative number of genes on 
chromosome I in both challenge groups. While many regulated hypothetical genes contain 
putative conserved domain sequences such as permeases, ATPases, and Rf2 transcriptional 
regulator, multiple hypothetical genes with no predicted function were seen regulated 
across both strains. Specifically, in oyster hemolymph challenges DUF-family motif 
hypothetical genes VP0752 and VP0836 were up-regulated, while DUF-motif containing 
hypothetical gene VPA1284 was down-regulated. It should be noted that VPA1284 was 
the only hypothetical gene on chromosome II which AQ4037 significantly down-regulated 
in oyster hemolymph challenges. 
Transport, Attachment, and Virulence expression in oyster hemocyte and Caco-2 
cytotoxicity assays. Tx2103 up-regulated several sodium symporter genes in oyster 
hemolymph challenges, which is intuitive when taking into account the both the halophilic 
nature of the bacterium and high sodium environment. Vibrios can produce ATP with a 




while lateral flagella are driven with a proton pump (133). In the oyster hemocyte assays 
Tx2103 up-regulated flagellar proteins including the hook protein and motor flagellum-
specific ATP synthase. Tx2103 down-regulated genes involved in potassium uptake and 
macrolide-specific efflux proteins. These results suggest that Tx2103 was able to take 
advantage of the halophilic environment of the hemolymph challenge. AQ4037 up-
regulated only 3 transport/secretion genes in oyster hemolymph. All up-regulated genes 
were ABC transporters, including one hemin transporter. The up-regulation of the hemin 
transporter corresponds with the increase in siderophore gene transcription seen in 
AQ4037 oyster hemolymph challenges. AQ4037 also down-regulated few 
transport/secretion genes, of note the outer membrane protein ompV was down-regulated, 
which functions in NaCl regulation in Vp (134). 
The general functions of transport/secretion genes regulated in Caco-2 trials were 
different from hemolymph trials in both strains. Tx2103 up-regulated a single 
sodium/proline symporter along with multiple outer membrane proteins, secretion proteins, 
and a sodium-type flagellar protein precursor. Down-regulated genes included multiple 
ABC transporters, a sodium/glutamate symporter, MSHA-related attachment proteins, and 
ExbD2, a TonB system transport protein. The TonB system in gram-negative bacteria 
helps to transmit the proton motive force from the cytoplasmic membrane to the outer 
membrane, where it can be used to fuel multiple functions (135). 
In Caco-2 challenges, AQ4037 preferred motility to attachment. AQ4037 up-
regulated several motility-related genes including flhB, flhF, CheZ, flgE, and two flagellar 
and biofilm-related proteins. 42% of all down-regulated genes in AQ4037 were adhesion 




Very few virulence factors were detected as being significantly regulated in any 
strain or challenge group. These results can be explained by the relationship between 
quorum-sensing, nutrient density, and virulence. It has been shown that surface sensing in 
Vp promotes genetic expression of colonization and virulence genes (106, 136, 137). 
Furthermore, virulence factors such as the T3SS can be induced by the limitation of certain 
nutrients such as iron and calcium (136) and under certain cell densities (100). 
Specifically, Vp and V. harveyi have been shown to secrete virulence factors under low-
density conditions through an auto-inducing signaling cascade. This has been demonstrated 
in an opposite manner to Enterohemarrogenic E. coli, which secrete T3SS proteins at high 
cell densities (138). Experiments showing virulence production under low-density 
conditions occurred over a 14 hour time frame, while the short nature of these tissue 
exposures could have not provided the time necessary to promote observable changes in 
genetic expression. It should also be noted that while limited calcium is a proven promoter 
of T3SS gene expression, both challenges took place in calcium rich environments. 
 Overall, many significant differences in genetic expression were found between Vp 
strains in oyster hemocyte bactericidal assays. These differences were further illustrated by 
analyzing the transcriptomic response of Vp in a cytotoxic-inducing environment and 
comparing the results to Vp-hemocyte gene regulation. This study has demonstrated that 
tdh+/trh- and tdh-/trh+ strains of Vp significantly differ in many functional categories when 
exposed to oyster hemocyte. 






CONCLUSIONS AND FUTURE DIRECTIONS 
Potential pathogen Vp subgroups displayed unique and separate characteristics 
throughout this project. Only 130 potentially pathogenic Vp strains out of thousands 
isolated from the northern Gulf of Mexico were found to contain tdh and/or trh. 
Approximately half of these strains came from sediment, the remaining strains were 
isolated evenly between water and oyster tissue. Only three tdh-/trh+ isolates were found 
over four years of sampling, and all occurred in sediment at one site. REP and ERIC-PCR 
showed that these strains shared strong homology but were not identical. Thesis data 
suggest that in the northern Gulf of Mexico the environment may be more favorable to 
potentially pathogenic Vp that carry tdh. 
A representative tdh+/trh- Vp strain up-regulated metabolic, hypothetical, transport, 
and secretion-related genes at a significantly higher frequency than a representative tdh-
/trh+ strain in oyster hemocyte bactericidal assays. Furthermore, the tdh-/trh+ strain 
induced multiple stress response genes. These same expression patterns were not seen in 
Caco-2 cytotoxicity assays. The oyster bactericidal assay contained lower nutrients and 
were more indicative of natural conditions compared to the Caco-2 cytotoxicity assays. It 
is unsure if the differences in genetic expression were due to the lower nutrient 
environment or the presence of hemocytes or both.  
The potential pathogen subgroups of Vp did not display any significant difference 
in bacterial oyster hemocyte assays. This suggests that neither tdh+/trh- nor tdh-/trh+ 
subgroups are better equipped to deal with hemocyte exposure. Differences in regulated 
genes between subgroups is therefore slightly more likely due to be a response of 




The results of these experiments indicate that metabolism plays a strong role in 
how potentially pathogenic Vp isolates are distributed in the environment and that 
metabolic factors may be useful indicator of potentially pathogenic strains. Future research 
should acknowledge that this data used representative clinical strains for expression 
studies. The rarity of tdh-/trh+ isolates in the northern Gulf of Mexico is a double-edged 
sword- it is both an interesting discovery and a limitation to the significance that can be 
placed on data acquired from potential pathogen subgroup analysis. An experiment which 
is able to test a large collection of environmental and clinical tdh-/trh+ isolates could help 
increase the significance of these findings. 
The functions of all organisms are extremely complex at the molecular level. A 
strong assessment of relevant genetic characteristics, such as transcriptomics, in Vp 
provides a good framework for additional research but cannot be generalized. 
Environment, time, and cell densities are some of many variables which affect Vp. The 
combination of genetic and organism-level experiments help to ensure a lucid 












OLIGONUCLEOTIDE PRIMERS USED IN THIS STUDY 
Name     Sequence    Reference 
 
tdh_89F  TCCCTTTTCCTGCCCCC     (139) 
tdh_321R  CGCTGCCATTGTATAGTCTTTATC   (139) 
trh_20F  TTGCTTTCAGTTTGCTATTGGCT   (139) 
trh_292R  TGTTTACCGTCATATAGGCGCTT   (139) 
tl_884F  ACTCAACACAAGAAGAGATCGACAA   (139) 
tl_1091R  GATGAGCGGTTGATGTCCAAA    (139) 
VP1669F  TACCGAGTTGCCAACGTG   This Study 
VP1669R  GATTGTTCCGCGATTTCTTG   This Study 
VP1670F  ACCGATTACTCAAGGCGATG   This Study 
VP1670R  TACGTTGTTGGCGTGATTGT   This Study 
VP1686F  CAAAAGCGATCACAAAAGCA   This Study 
VP1686R  AGCGACTTAACGGCATCATC   This Study 
VP1689F  AAGGTTGGCAAAAAGCGTTA   This Study 
VP1689R  GCTCTTCAACGAGCCAAGAG   This Study 
VP1694F  ACGATGCGACCAACAGTGTA   This Study 
VP1694R  TTTTAATTGCATCGGTGACG   This Study 
VPA1327F  TGGCGAAAGAGCCATTAGAT   This Study 
VPA1327R  TCAACTCCAAATTCGCCTTC   This Study 
VPA1335F  ATGTAACGGCGGCTAGCTTA   This Study 




VPA1339F  GATTCGCGGAACTCAAGAAG   This Study 
VPA1339R  CTTGTCCGAGATCAACGTCA   This Study 
VPA1346F  GGCTCTGATCTTCGTGAA   This Study 
VPA1346R  GATGTTTCAGGCAACTCTC   This Study 
VPA1354F  AATTGGCCGAGCCAACTTT   This Study 
VPA1354R  GTCATCCGGTTCTTGTGTAA   This Study 
VPA1362F  CTGCAGGTATCGCATCTTCA   This Study 
VPA1362R  TTAGAACCAACCGACGAAGC   This Study 
Beta_vscC2_F  GTACTTTGCTGTCTAACC    (58) 
Beta_vscC2_R CTTACTCTTAACTTCCGACG    (58) 
Beta_vscS2_F  TTGATGTTGTTTCGGCTAGC    (58) 
Beta_vscS2_R  CCACCGCCGAACTCGGCTAACAAG   (58) 
Beta_vopB2_F GAGCCTGTTGCTCTATGGAGCCAGG   (58) 
Beta_vopB2_R CGACACAGAACGCAATGCTTGCTCG   (58) 
Beta_vopC_F  AACCAACTTGCGACTAAATC    (58) 
Beta_vopC_R  TCCCGACAGTTTTTCTGCAC    (58) 
GS-PCR_F  TAATGAGGTAGAAACA     (43) 







VIBRIO PARAHAEMOLYTICUS ISOLATES USED IN CYTOTOXICITY AND  
HEMOCYTE BACTERICIDAL ASSAYS 
Isolate Storage Code  tlh tdh trh  environmental/clinical 
AK strain    + + +  clinical 
BAA-238    + + +  clinical 
F11     + + +  clinical 
Vp2007-095    + + +  clinical 
Vp2006-016    + + +  environmental 
Vp2007-023    + + +  environmental 
Vp2007-052    + + +  environmental 
Vp2007-057    + + +  environmental 
Vp2009-015    + + +  environmental 
Vp2009-026    + + +  environmental 
Tx2103    + + -  clinical 
CT6636    + + -  clinical 
Vp2006-001    + + -  environmental 
Vp2006-004    + + -  environmental 
Vp2006-008    + + -  environmental 
Vp2006-041    + + -  environmental 
Vp2007-064    + + -  environmental 
Vp2007-070    + + -  environmental 
Vp2007-106    + + -  environmental 




AQ4037    + - +  clinical 
KCHD 613    + - +  clinical 
Vp2007-005    + - +  environmental 
Vp2007-007    + - +  environmental 
Vp2007-025    + - +  environmental 
FIHES     + - -  clinical 
901128    + - -  clinical 
NY3547    + - -  clinical 
Vp2006-009    + - -  environmental 
Vp2007-004    + - -  environmental 
Vp2007-017    + - -  environmental 







GENES SIGNIFICANTLY UP OR DOWN-REGULATED IN VP OYSTER  
 
HEMOCYTE AND CACO-2 CHALLENGES 
 
Locus      Gene Name      Description 
Tx2103 – Oyster – Down-regulated 




A79_5812 ruvB holliday junction DNA helicase RuvB 
VP2628 
 
membrane-bound lytic murein transglycosylase C 
VPA0223 
 
putative HlyD family secretion protein 
VPA0223 
 
putative HlyD family secretion protein 
VP0535 lspA signal peptidase II 
A79_0503 
 
potassium uptake protein, TrkH family 
VPA0409 
 
plasma membrane protein involved in salt tolerance 
A79_4324 
 
Flp pilus assembly protein 
A79_5698 
 




































sensor histidine kinase 
A79_2580 proB glutamate 5-kinase 
 
Tx2103 – Oyster – Up-regulated 
A79_5012   





ribosomal protein L13 
VP0442 
 















purine nucleoside phosphorylase 


















putative acyl-CoA dehydrogenase 
VPA1122 
 
putative aldehyde dehydrogenase 
VPA1122 
 
putative aldehyde dehydrogenase 
A79_0469 
 




































cyclic nucleotide binding protein/2 CBS domains 
VC1273 
 
extracellular solute-binding protein, family 7 
VP1597 
 
putative N6-adenine-specific DNA methylase 
A79_3591 
 
sodium/solute symporter, putative 
A79_3591 
 









putative outer membrane protein 
VP0778 
 
flagellar hook protein 
VP0778 
 
flagellar hook protein 
VPA1533   putative flagellum-specific ATP synthase 
 
Tx2103 – Caco-2 – Down-regulated 
A79_0634   lactaldehyde reductase 















deCa-heme c-type cytochrome 
A79_2025 
 











A79_4475 cydB cytochrome D ubiquinol oxidase, subunit II 
A79_4818 
 
chromosome partition protein MukB 
A79_4898 
 






NADP-dependent fatty aldehyde dehydrogenase 
VCA0859 
 
oxidoreductase, aldo/keto reductase 2 family 
VP0028 
 
zinc-binding alcohol dehydrogenase 
VP0482 
 






















putative hydroxymethylglutaryl-CoA lyase 
VPA1147 
 






conserved hypothetical protein 
A79_1516 
 
conserved hypothetical protein 
A79_1943 
 
conserved hypothetical protein 
A79_4920 
 
conserved hypothetical protein 
A79_5405 
 
conserved hypothetical protein 
A79_6125 
 






































































ABC transporter, permease/ATP-binding protein 
A79_2318 
 
putative sugar transport system 
A79_3700 
 
multidrug resistance protein A 
VP0415 
 
putative general secretion pathway protein A 
VP0660 
 
putative type IV pilin 
VP0702 
 
SecY interacting protein Syd 
VP1218 
 
putative outer membrane protein precursor 
VP1435 
 
putative sodium/glutamate symporter 
VP2702 
 
MSHA biogenesis protein MshN 
VPA0154 
 
TonB system transport protein ExbD2 
VPA0604 
 
ABC transporter, periplasmic substrate-binding protein 
VPA1166 
 
chloride channel protein 
A79_2667 
 
polar flagellin A 
A79_3151 
 
putative biofilm-associated surface protein 
VPA1329   putative traA protein 
 
Tx2103 – Caco-2 – Up-regulated 
A79_0026   chitobiase 
A79_0678 
 
ABC transporter, ATP-binding protein 





















prolipoprotein diacylglyceryl transferase 
A79_5242 
 
thiol:disulfide interchange protein DsbC 
A79_5484 
 
conserved hypothetical protein 
A79_6050 
 
cell wall-associated hydrolase 
A79_6198 hmgA homogentisate 1,2-dioxygenase 
VP0041 
 
ATP-dependent DNA helicase Rep 
VP0157 
 
ATP-dependent DNA helicase RecG 
VP0481 
 
glutamate synthase, small subunit 
VP0513 lysS lysyl-tRNA synthetase 
VP0665 
 






penicillin-binding protein 2 
VP1255 
 















rRNA methylase, SpoU family 
VP2911 
 
DNA-binding protein HU-2 
VP2942 
 
soluble pyridine nucleotide transhydrogenase 
























conserved hypothetical protein 
A79_0604 
 
conserved hypothetical protein 
A79_1952 
 
conserved hypothetical protein 
A79_3581 
 
conserved hypothetical protein 
A79_3692 
 
conserved hypothetical protein 
A79_4983 
 































































sensory box/ggdef family protein 
VP0569 
 
DNA-binding response regulator PhoB 
VP0833 fur ferric uptake regulator 
VP2574 
 
GTP-binding protein LepA 
VP2857 
 
putative periplasmic protein CpxP 
A79_0499 
 
ABC-type multidrug efflux pump 
A79_1271 
 






putative msha pilin protein msha 
A79_1627 
 
amino-acid abc transporter binding protein 
A79_1684 putP sodium/proline symporter 
A79_2015 
 
outer membrane protein 
VPA0721 
 
rough colony protein RcpA 
VPA0856 
 
putative transmembrane transport protein 
A79_1849 
 
methyl-accepting chemotaxis protein 
VPA1539 
 
putative sodium-type flagellar protein MotY precursor 
VPA1541 
 
flagellar motor switch protein 
A79_3703 
 
autoinducer 2 sensor kinase/phosphatase LuxQ 
VPA1218   putative secretion protein 
 
AQ4037 – Oyster – Down-regulated 













A79_5966 pyk pyruvate kinase 










































GTP-binding protein Obg/CgtA 
A79_4778 
 
transcriptional regulatory protein FixJ 
VP2577 rseA sigma-E factor negative regulatory protein RseA 
VP2772 rpsG 30S ribosomal protein S7 
VPA1538 
 
putative two-component response regulator 
VP0535 lspA signal peptidase II 
VP1194 
 






putative outer membrane protein OmpV 
VPA0318 
 
putative outer membrane protein OmpV 





AQ4037 – Oyster – Up-regulated 
A79_3197 
 
vibrioferrin biosynthesis protein PvsA 
A79_4687 
 
redoxin domain protein 
A79_6044 
 
smr/muts family protein 
VC1144 
 
ATP-dependent Clp protease, ATP-binding subunit ClpA 
VC2260 
 













acyl carrier protein 
VP2873 fumC fumarate hydratase 
VP2873 fumC fumarate hydratase 
VPA0454 
 
putative DNA-binding stress protein 
VPA1510 
 




































transcriptional regulator, MarR family 
A79_3059 
 
YheO domain protein 
A79_3585 
 
cyclic nucleotide binding protein/2 CBS domains 
A79_4208 
 
RNA polymerase sigma factor 32 (RpoS) 
A79_4376 
 
putative LysR-family transcriptional regulator 
VC0415 
 
rod shape-determining protein MreB 
VP2632 
 
transcriptional regulator, LacI family 
A79_0162 
 
peptide transport system ATP-binding protein SapF 
VPA0133 
 
putative ABC transporter substrate-binding protein 
VPA0423   
hemin ABC transporter, periplasmic hemin-binding 
protein HutB 
 
AQ4037 – Caco-2 – Down-regulated 
A79_0177 metC cystathionine beta-lyase 
A79_0319   RNA pseudouridine synthase family protein 
A79_0891   acetyltransferase 




A79_1845   efflux ABC transporter, permease protein 
A79_2269   glycosyl transferase, family 39 
A79_2810   4-aminobutyrate aminotransferase 
A79_3146   oxidoreductase alpha (molybdopterin) subunit 
A79_3363   khg/kdpg aldolase 
A79_4285   tellurite resistance protein 
A79_4432   ferredoxin-dependent glutamate synthase 1 
VC0305   ATP-dependent RNA helicase 
VP0033   protoporphyrinogen oxidase 
VP0735   
2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol 
hydroxylase 
VP0829   N-acetylglucosamine-6-phosphate deacetylase 
VP1048 ruvC Holliday junction resolvase 
VP1301   exodeoxyribonuclease I 
VP1646   aconitate hydratase 
VP2186   bacteriocin production protein 
VP2316   uridylate kinase 
VP2552   DNA mismatch repair protein 
VP2885   DNA-binding protein Fis 
VP3035   Sua5/YciO/YrdC family protein 
VPA0278   isopentenyl pyrophosphate isomerase 
VPA0867   DnaJ-related protein 
VPA1158   acetyl-CoA synthase 
VPA1201   periplasmic nitrate reductase, cytochrome c-type protein 
A79_0377   YjqA 
A79_0876   conserved hypothetical protein 
A79_1669   conserved hypothetical protein 
A79_1851   hypothetical protein 
A79_2215   hypothetical protein 
A79_2446   hypothetical protein 
A79_2553   conserved hypothetical protein 
A79_4489   hypothetical protein 
A79_4496   hypothetical protein 
A79_4782   hypothetical protein 
A79_5417   conserved hypothetical protein 
A79_5997   conserved hypothetical protein 
VCA1065   hypothetical protein 
VP0913   hypothetical protein 
VPA0443   hypothetical protein 
VPA0720   hypothetical protein 
VPA0748   hypothetical protein 
VPA0772   hypothetical protein 
VPA1027   hypothetical protein 




VPA1599   hypothetical protein 
VPA1692   hypothetical protein 
A79_0638   transcriptional regulator, AraC family 
A79_1285   protein in PtsN-ptsO intergenic region 
A79_4639   two-component response regulator 
A79_5987   twin-arginine translocation pathway signal 
VCA0682   transcriptional regulator UhpA 
VP1755   putative histidine kinase 
A79_1439   permease of the drug/metabolite transporter 
A79_3159   cation efflux system 
A79_3605   MadN protein 
A79_3675   glutathione peroxidase 
A79_3727 napD NapD protein 
A79_4966   permease of the major facilitator superfamily 
VP3066   putative amino acid ABC transporter, permease protein 
VPA0153   TonB system transport protein ExbB2 
VPA0650   heat shock protein 70 family protein 
VPA0721 rcpA rough colony protein RcpA 
VPA1131   putative periplasmic binding protein-related protein 
VP1535 uspE putative stress protein 
VP2159   
putative methyl-accepting chemotaxis transmembrane 
protein 
VP2254   flagellar protein FliS 
VPA1554   LafF 
VPA0939   putative adhesin 
VPA1307   putative adhesion protein 
A79_0585   VcsR2 
A79_2095   type IV pilus assembly protein PilZ 
 
AQ4037 – Caco-2 – Up-regulated 
A79_0426 tdh L-threonine 3-dehydrogenase 
A79_1191 moaD molybdopterin converting factor, subunit 1 






DNA gyrase/topoisomerase IV, A subunit 
A79_3168 
 
ATP-dependent Zn protease 
A79_4292 glpK glycerol kinase 
A79_4687 
 
redoxin domain protein 
A79_5041 menB naphthoate synthase 
A79_5105 mobA molybdopterin-guanine dinucleotide biosynthesis protein A 
A79_5288 
 
soluble lytic murein transglycosylase 
A79_5815 ruvC crossover junction endodeoxyribonuclease RuvC 
A79_5816 aspS aspartyl-tRNA synthetase 
A79_6062 
 










30S ribosomal protein S2 
VP0152 greB transcription elongation factor GreB 
VP0202 
 
putative sugar-phosphate nucleotide transferase 
VP0231 
 
putative UDP-galactose phosphate transferase 
VP0507 
 
branched chain amino acid transport system II carrier protein 















DNA polymerase III subunit epsilon 
VP2055 
 
acyl carrier protein S-malonyltransferase 
VP2055 
 
acyl carrier protein S-malonyltransferase 
VP2056 
 
3-oxoacyl-(acyl carrier protein) synthase 
VP2071 
 
fatty acid metabolism regulator 
VP2096 
 
molybdenum cofactor biosynthesis protein A 
VP2194 
 
3-oxoacyl-[acyl-carrier-protein] synthase I 









DNA polymerase IV 
VP2355 
 
peptidyl-prolyl cis-trans isomerase A 
VP2437 
 




VP2676 tldE PmbA protein (peptidase) 
VPA0263 
 






putative cytochrome b561 
VPA0466 
 






putative acyl-CoA dehydrogenase 
VPA0648 
 
putative DOPA-dioxygenase-related protein 
VPA1157 
 
electron transfer flavoprotein, alpha-subunit 
VPA1498 
 
putative L-lactate permease 
A79_0469 
 
conserved hypothetical protein 
A79_0469 
 
conserved hypothetical protein 
A79_0903 
 
conserved hypothetical protein 
A79_1374 
 
Hypothetical - FOG ggdef domain 
A79_1810 
 
conserved hypothetical protein 
A79_2007 
 
conserved hypothetical protein 
A79_4386 
 
conserved hypothetical protein 
A79_4827 
 
































































































hypothetical adenine-specific methylase YfcB 
A79_4974 
 










DNA-binding response regulator 
VP2793 
 
























long-chain fatty acid transport protein 
A79_2788 
 
magnesium and cobalt efflux protein CorC 
A79_3241 
 
putative alkylphosphonate ABC tranporter 
A79_4905 brnQ branched-chain amino acid transport system II carrier protein 
VC1361 
 
amino acid ABC transporter, permease protein 
VP0507 
 









putative outer membrane protein TolC 
VP2091 
 
oligopeptide ABC transporter, periplasmic oligopeptide-binding protein 
VP3069 
 
ATP synthase subunit B 
VPA0150 
 
putative ferrichrome-iron receptor 
A79_1856 
 
putative protein F-related protein 






flagellar biosynthesis protein FlhF 
VP2230 
 
chemotaxis protein CheZ 
A79_0745 
 
putative biofilm-associated surface protein 








GENES DISPLAYING SIGNIFICANT INTERSTRAIN VARIATION IN GENE  
 
EXPRESSION AT IDENTICAL TIME POINTS AND CHALLENGE GROUPS 
 
Higher in Tx2103 – 1h – Oys 
VPA1419 
 
putative 3-hydroxyisobutyrate dehydrogenase 
VPA1510 
 






putative long-chain-fatty-acid-CoA ligase 
VP3027 
 
thiamine biosynthesis protein ThiC 
VP0540 cstA putative carbon starvation protein A 
VP3019 
 
putative multidrug resistance protein 
VP0540 cstA putative carbon starvation protein A 
A79_2779 thiF thiazole biosynthesis adenylyltransferase ThiF 
VP3027 
 
thiamine biosynthesis protein ThiC 
A79_2782 thiH thiazole biosynthesis protein ThiH 
VP3023 thiG thiazole synthase 
A79_2777 thiC thiamine biosynthesis protein ThiC 
A79_2779 thiF thiazole biosynthesis adenylyltransferase ThiF 
A79_2782 thiH thiazole biosynthesis protein ThiH 
VP3022 
 
thiamine biosynthesis protein ThiH 
VP3022 
 
thiamine biosynthesis protein ThiH 
A79_2777 thiC thiamine biosynthesis protein ThiC 









sulfur carrier protein ThiS 
VP3024 
 
sulfur carrier protein ThiS 
VPA0223 
 
putative HlyD family secretion protein 
VC1565 
 
outer membrane protein TolC, putative 
VP3019 
 
putative multidrug resistance protein 
A79_2785 
 

































Higher in AQ4037 – 1h – Oys 
A79_0425 kbl 2-amino-3-ketobutyrate coenzyme A ligase 
A79_4236 
 
putative efflux pump component MtrF 
A79_4181 
 






thiol:disulfide interchange protein 
A79_1369 cadA cadmium-translocating P-type ATPase 
VPA1533 
 







VP0474   hypothetical protein 
 
Higher in Tx2103 – 4h – Oys 
A79_5012 
 
































putative acyl-CoA carboxyltransferase beta chain 
VPA1122 
 
putative aldehyde dehydrogenase 
VPA0301 
 
methionine sulfoxide reductase A 
VPA1419 
 









putative acyl-CoA dehydrogenase 
VPA1122 
 
putative aldehyde dehydrogenase 
A79_3591 
 
sodium/solute symporter, putative 
VPA1157 
 










VP1281 rpmI 50S ribosomal protein L35 
VP2030 
 
30S ribosomal protein S1 
VPA1152 
 
putative long-chain-fatty-acid-CoA ligase 
VP3027 
 
thiamine biosynthesis protein ThiC 
VP3027 
 







A79_2782 thiH thiazole biosynthesis protein ThiH 
VP3023 thiG thiazole synthase 
VP3023 thiG thiazole synthase 
VP3022 
 
thiamine biosynthesis protein ThiH 
VP0540 
 
putative carbon starvation protein A 
VP3022 
 
thiamine biosynthesis protein ThiH 
A79_2782 thiH thiazole biosynthesis protein ThiH 
VP0540 
 








A79_2777 thiC thiamine biosynthesis protein ThiC 
A79_3579 treP pts system, trehalose-specific iibc component 
A79_6073 
 
amino acid ABC transporter, permease protein 
VP2867 
 






putative ABC transporter, ATP-binding protein 
VP3019 
 
putative multidrug resistance protein 
VPA0166 
 
putative outer membrane protein 
VPA1542 
 
























transcriptional regulatory protein FixJ 
VP2386   glycerol kinase 
 
Higher in AQ4037 – 4h – Oys 
























conserved hypothetical protein 
A79_4798 
 




























A79_2580 proB glutamate 5-kinase 
 







A79_4609 ilvB acetolactate synthase, large subunit, biosynthetic type 
A79_2276 
 






putative sugar transport system 
VP1903 
 
DNA polymerase III subunit epsilon 
VP0710 
 
PTS system, trehalose-specific IIBC component 
VP1450 
 
putative component of anaerobic dehydrogenase 
A79_4818 
 
chromosome partition protein MukB 
A79_4475 cydB cytochrome D ubiquinol oxidase, subunit II 
A79_5288 
 




A79_6250 purT phosphoribosylglycinamide formyltransferase 2 
A79_6218 
 
NADP-dependent fatty aldehyde dehydrogenase 
VPA0452 
 
putative cytochrome b561 
VP3007 
 
ATP-dependent DNA helicase RecQ 
VPA1155 
 




A79_6250 purT phosphoribosylglycinamide formyltransferase 2 
VP1724 
 













putative riboflavin deaminase 
VPA1157 
 
electron transfer flavoprotein, alpha-subunit 
VP3022 
 
thiamine biosynthesis protein ThiH 
VP0260 
 
50S ribosomal protein L2 
VP3022 
 
thiamine biosynthesis protein ThiH 
VP3027 
 


















putative transmembrane protein 
VP2310 
 
surface antigen (outer membrane protein assembly factor YaeT) 
VP1526 
 




putative permease of ABC transporter 
A79_5938 
 






arginine ABC transporter, permease protein 
A79_2667 
 
polar flagellin A 
VP2693 
 






putative Type III secretion protein Spa33 
VP0660 pilV putative type IV pilin 
A79_0729 pilP type IV pilus 
A79_2291 
 




























































hypothetical adenine-specific methylase YfcB 
A79_4974 
 
AraC-type DNA-binding domain-containing protein 
A79_4210 pcm protein-L-isoaspartate O-methyltransferase 
VP0428 
 






















VP2927 nusG transcription antitermination protein NusG 
VP2294   putative SAM-dependent methyltransferase 
 
Higher in AQ4037 – 1h - Caco-2 
A79_4492   acyl-CoA dehydrogenase 
VP1036 mukE condesin subunit E 









putative glutathione S-transferase 






peptidase, M20A family 








VP2032 sohB sohB protein, peptidase U7 family 
VP0665 
 
transglycosylase, Slt family 
A79_3669 
 




A79_1359 argG argininosuccinate synthase 
VP0722 
 






permease of the drug/metabolite transporter 
A79_1439 
 
permease of the drug/metabolite transporter 
VP1216 
 
multidrug resistance protein (bicyclomycin/multidrug efflux pump) 
VP2411 
 
putative tight adherence TadB-related transmembrane protein 
VP0706 
 
ABC transporter, ATP-binding protein 
A79_3190 
 
methyl-accepting chemotaxis protein 
VPA1541 
 
flagellar motor switch protein 
VP2811 
 
sodium-type polar flagellar protein MotX 
A79_3703 
 
autoinducer 2 sensor kinase/phosphatase LuxQ 
A79_1552 
 
putative msha pilin protein msha 
VP1657 
 
























conserved hypothetical protein 
A79_0244 
 




































conserved hypothetical protein 
A79_1374 
 






conserved hypothetical protein 
A79_2935 rpoN RNA polymerase sigma-54 factor 
VPA0619 
 
putative transcriptional regulator 
VP2450 
 
transcriptional regulator, MarR family 
A79_5786 
 
sensory box/ggdef family protein 
VP1016 infA translation initiation factor IF-1 
A79_5987 
 




VP3000 rho transcription termination factor Rho 
 





































pseudouridine synthase Rlu family protein 
A79_4485 
 
enoyl-CoA hydratase/carnithine racemase 
VP0826 asnB asparagine synthetase B 
VP1215 
 
ribosomal small subunit pseudouridine synthase A 
VC2090 
 
succinate dehydrogenase, hydrophobic membrane anchor 
protein 
A79_5302 pdhA pyruvate dehydrogenase E1 component, alpha subunit 






acetolactate synthase II, small subunit 
VPA1201 
 




VCA1060 ribB 3,4-dihydroxy-2-butanone 4-phosphate synthase 
A79_1193 moaB molybdenum cofactor biosynthesis protein B 
VPA0409 
 

































stability protein StbD, putative 
A79_6240 
 
bifunctional adenosylcobalamin biosynthesis protein CobP 
A79_6198 hmgA homogentisate 1,2-dioxygenase 
VP3022 
 
thiamine biosynthesis protein ThiH 
A79_2782 thiH thiazole biosynthesis protein ThiH 
VP3022 
 









sulfur carrier protein ThiS 
VC1273 
 
extracellular solute-binding protein, family 7 
A79_2015 
 
outer membrane protein 
A79_1549 rarD RarD protein 
A79_3159 
 
cation efflux system 
A79_2430 tolQ protein TolQ 
VP1511 
 
putative formate dehydrogenase-specific chaperone 
VP2329 
 
efflux pump component MtrF 
VP3066 
 
putative amino acid ABC transporter, permease protein 
VP1474 
 
putative capsule transport protein, OtnA protein 
VPA0721 
 
rough colony protein RcpA 
VP0170 
 
putative transmembrane ABC transporter protein 
VP2746 
 
fimbrial assembly protein 
VP2247 
 
flagellar assembly protein 
VPA1492 
 
methyl-accepting chemotaxis protein 
VPA1539 
 






msha biogenesis protein mshe 
A79_1885 
 









conserved hypothetical protein 
A79_0481 
 















































































































Rrf2 family protein 
A79_2942 
 
translation initiation factor IF-2 
VPA0974 
 
putative AraC-family transcriptional regulatory protein 
VPA0249 
 
putative transcription activator 
A79_0684 
 









nucleoside diphosphate kinase regulator 
VPA1214   putative transcriptional regulator 
 
Higher in AQ4037 – 4h – Caco-2 
VP2770 tuf elongation factor Tu 
VP0580 
 
antioxidant, AhpC/Tsa family 
VP0920 
 






ATP synthase subunit B 
VP0251 
 
putative cell division protein FtsN 
VP0580 
 
antioxidant, AhpC/Tsa family 















ATP synthase subunit C 
A79_0927 
 
putative transposase B 
A79_1499 gcvP glycine dehydrogenase 
VP1116 bioD dithiobiotin synthetase 
VP0202 
 
putative sugar-phosphate nucleotide transferase 
VP2437 
 
NupC family protein 
A79_4687 
 
redoxin domain protein 





















succinate dehydrogenase flavoprotein subunit 
A79_5522 
 






NADP-dependent fatty aldehyde dehydrogenase 
A79_3257 add adenosine deaminase 
A79_3588 
 
fumarate hydratase class II 1 
VP2188 
 
folylpolyglutamate synthase/dihydrofolate synthase 






isocitrate dehydrogenase, NADP-dependent 
A79_5522 
 













ATP-dependent DNA helicase rep 
VP1730 
 






type I restriction enzyme R protein 
VP2351 
 






acetyltransferase, gnat family 
VP2355 
 










A79_4262 ppiB peptidyl-prolyl cis-trans isomerase B 
VP1542 
 
cytochrome c oxidase, subunit CcoQ 
VP2032 
 
sohB protein, peptidase U7 family 
A79_0994 ectA L-2,4-diaminobutyric acid acetyltransferase 
VPA0618 
 
putative acyl-CoA dehydrogenase 
VP1543 
 
cytochrome c oxidase, subunit CcoO 
VP1878 
 
MutT/nudix family protein 
VP0483 
 
glutamate synthase, small subunit 
VP1542 
 






copper/silver resistance periplasmic protein 
VP1010 
 
pseudouridine synthase family 1 protein 
VP1586 
 






PTS system, fructose-specific IIA/FPR component 
VPA0060 
 
lysis protein - phage PP7 




A79_3653 leuA 2-isopropylmalate synthase 
VPA1498 
 






















putative integral membrane protein, possible transporter 
VP2091 
 




putative sodium/glutamate symporter 
A79_4067 
 









low-affinity zinc transport protein 
VP0591 
 
protein export protein SecF 
VP1995 
 
ABC transporter, ATP-binding protein 
VP2437 
 
NupC family protein 
A79_3700 
 
multidrug resistance protein A 
VPA0604 
 
ABC transporter, periplasmic substrate-binding protein 
VPA0424 
 
TonB system transport protein ExbD1 
VP2705 
 
MSHA biogenesis protein MshK 
VPA0807 
 












flagellar basal body rod modification protein 
A79_1856 
 






putative translocator protein PopD 
VP1665 
 
putative type III secretion protein 
A79_1019 
 
type III secretion outer membrane pore, YscC/HrcC family 
VPA1329 
 
putative traA protein 
VP1656 
 
putative translocator protein PopD 
VP1660 
 
putative regulator in type III secretion 
A79_0582 
 













































gonadoliberin III-related protein 
A79_1374 
 































































conserved hypothetical protein 
VC0464 
 
transcriptional regulator, LuxR family 
VP2294 
 






transcriptional regulator, AraC family 
VC0464 
 
transcriptional regulator, LuxR family 
VP2793 
 
cyclic AMP receptor protein 
VPA1276 
 









transcriptional regulator, DeoR family 
A79_0232 
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